Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transmembrane transporter activity	TTYH1 ABCA4 PKD1L2 SLC30A1 TMC3 CHRM5 SLC12A5 SLC35D1 SLC22A8 TRPM8 SLC49A3 STRA6 KCNK17 MFSD1 SLC27A4 SLC25A41 SLC2A8 GJC1 ABCC11 ABCC9 CLDN4 FLVCR2 SLC7A14 SLC5A3 SLC5A4 SLC7A4 SLC12A2 SLC12A4 SLC16A5 SLC16A4 SLC14A1 DISP1 MCOLN3	3.57e-07	1180	213	33	GO:0022857
GeneOntologyMolecularFunction	transporter activity	TTYH1 ABCA4 PKD1L2 SLC30A1 TMC3 CHRM5 SLC12A5 SLC35D1 SLC22A8 TSPO TRPM8 SLC49A3 STRA6 KCNK17 MFSD1 SLC27A4 SLC25A41 SLC2A8 GJC1 ABCC11 ABCC9 CLDN4 FLVCR2 SLC7A14 SLC5A3 SLC5A4 SLC7A4 SLC12A2 SLC12A4 SLC16A5 SLC16A4 SLC14A1 DISP1 MCOLN3	8.85e-07	1289	213	34	GO:0005215
GeneOntologyMolecularFunction	scavenger receptor binding	FPR1 FPR2 FPR3	1.18e-05	5	213	3	GO:0005124
GeneOntologyMolecularFunction	N-formyl peptide receptor activity	FPR1 FPR2 FPR3	1.18e-05	5	213	3	GO:0004982
GeneOntologyMolecularFunction	histone H3K4 monomethyltransferase activity	SETD1A KMT2B KMT2D	6.44e-05	8	213	3	GO:0140945
GeneOntologyMolecularFunction	secondary active transmembrane transporter activity	SLC30A1 SLC12A5 SLC35D1 SLC22A8 MFSD1 SLC2A8 SLC5A3 SLC5A4 SLC12A2 SLC12A4 SLC16A5 SLC16A4	8.49e-05	296	213	12	GO:0015291
GeneOntologyMolecularFunction	inorganic anion transmembrane transporter activity	TTYH1 CHRM5 SLC12A5 SLC22A8 ABCC11 ABCC9 CLDN4 SLC12A2 SLC12A4	9.46e-05	171	213	9	GO:0015103
GeneOntologyMolecularFunction	potassium:chloride symporter activity	SLC12A5 SLC12A2 SLC12A4	9.59e-05	9	213	3	GO:0015379
GeneOntologyMolecularFunction	histone H3K4 trimethyltransferase activity	SETD1A KMT2B KMT2D	1.36e-04	10	213	3	GO:0140999
GeneOntologyMolecularFunction	active transmembrane transporter activity	ABCA4 SLC30A1 SLC12A5 SLC35D1 SLC22A8 MFSD1 SLC2A8 ABCC11 ABCC9 SLC5A3 SLC5A4 SLC12A2 SLC12A4 SLC16A5 SLC16A4	1.96e-04	477	213	15	GO:0022804
GeneOntologyMolecularFunction	ammonium channel activity	SLC12A5 SLC12A2 SLC12A4	2.45e-04	12	213	3	GO:0008519
GeneOntologyMolecularFunction	G protein-coupled neurotransmitter receptor activity	CHRM1 CHRM5 GABBR1	3.16e-04	13	213	3	GO:0099528
GeneOntologyMolecularFunction	complement receptor activity	FPR1 FPR2 FPR3	3.99e-04	14	213	3	GO:0004875
GeneOntologyMolecularFunction	RAGE receptor binding	FPR1 FPR2 FPR3	4.95e-04	15	213	3	GO:0050786
GeneOntologyMolecularFunction	retinol transmembrane transporter activity	ABCA4 STRA6	6.70e-04	4	213	2	GO:0034632
GeneOntologyMolecularFunction	lipid transmembrane transporter activity	ABCA4 SLC22A8 STRA6 SLC27A4 ABCC11	1.10e-03	73	213	5	GO:0170055
GeneOntologyMolecularFunction	protein-lysine 6-oxidase activity	LOXL1 LOXL2	1.11e-03	5	213	2	GO:0004720
GeneOntologyMolecularFunction	symporter activity	SLC12A5 SLC5A3 SLC5A4 SLC12A2 SLC12A4 SLC16A5 SLC16A4	1.16e-03	150	213	7	GO:0015293
GeneOntologyMolecularFunction	histone H3K4 methyltransferase activity	SETD1A KMT2B KMT2D	1.19e-03	20	213	3	GO:0042800
GeneOntologyMolecularFunction	monoatomic anion transmembrane transporter activity	TTYH1 CHRM5 SLC12A5 CLDN4 SLC12A2 SLC12A4 MCOLN3	1.20e-03	151	213	7	GO:0008509
GeneOntologyMolecularFunction	histone H3 methyltransferase activity	SETD1A KMT2B PRDM8 KMT2D	1.22e-03	44	213	4	GO:0140938
GeneOntologyMolecularFunction	transmembrane signaling receptor activity	EPHB6 OR2L8 OR2L3 PECAM1 CHRM1 CHRM5 OR1E1 OR1E2 CNR2 MRC1 OR10H5 GPR31 FPR1 FPR2 FPR3 ABCC9 CLDN4 EDA OR10X1 OR4C15 OR10G2 OR10H2 OR10H1 OR4A16 GABBR1 EPHA5 OR2A2	1.25e-03	1353	213	27	GO:0004888
GeneOntologyMolecularFunction	G protein-coupled receptor activity	OR2L8 OR2L3 CHRM1 CHRM5 OR1E1 OR1E2 CNR2 OR10H5 GPR31 FPR1 FPR2 FPR3 OR10X1 OR4C15 OR10G2 OR10H2 OR10H1 OR4A16 GABBR1 OR2A2	1.29e-03	884	213	20	GO:0004930
GeneOntologyMolecularFunction	retinal binding	ABCA4 STRA6 RBP3	1.38e-03	21	213	3	GO:0016918
GeneOntologyMolecularFunction	channel activity	TTYH1 PKD1L2 TMC3 CHRM5 SLC12A5 TRPM8 KCNK17 GJC1 ABCC9 CLDN4 SLC12A2 SLC12A4 SLC14A1 MCOLN3	1.58e-03	525	213	14	GO:0015267
GeneOntologyMolecularFunction	passive transmembrane transporter activity	TTYH1 PKD1L2 TMC3 CHRM5 SLC12A5 TRPM8 KCNK17 GJC1 ABCC9 CLDN4 SLC12A2 SLC12A4 SLC14A1 MCOLN3	1.61e-03	526	213	14	GO:0022803
GeneOntologyMolecularFunction	chloride:monoatomic cation symporter activity	SLC12A5 SLC12A2 SLC12A4	1.81e-03	23	213	3	GO:0015377
GeneOntologyCellularComponent	secretory vesicle	PRAMEF7 GAD2 SPAM1 GALNS MLEC SPTAN1 PECAM1 BCL2L1 NHLRC2 ADAM10 MFGE8 GLA HP FGA PLAT PLAUR LRRC7 TMEM95 GP2 DMXL2 DSC1 SLC2A8 FPR1 FPR2 TMPRSS12 ABCC9 PRAMEF12 PRAMEF8 PIKFYVE LOXL1 GABBR1 CYB561	1.96e-06	1246	217	32	GO:0099503
GeneOntologyCellularComponent	secretory granule	PRAMEF7 SPAM1 GALNS MLEC SPTAN1 PECAM1 NHLRC2 ADAM10 MFGE8 GLA HP FGA PLAT PLAUR LRRC7 TMEM95 GP2 DMXL2 DSC1 FPR1 FPR2 TMPRSS12 ABCC9 PRAMEF12 PRAMEF8 PIKFYVE LOXL1 CYB561	2.35e-06	1014	217	28	GO:0030141
GeneOntologyCellularComponent	acrosomal vesicle	PRAMEF7 SPAM1 MFGE8 TMEM95 TMPRSS12 ABCC9 PRAMEF12 PRAMEF8 LOXL1	3.14e-04	206	217	9	GO:0001669
MousePheno	abnormal cecum morphology	PRAMEF7 ZNF226 OR1E1 OR1E2 CNR2 PRAMEF12 PRAMEF8 SLC12A2	1.92e-05	99	162	8	MP:0000494
MousePheno	abnormal large intestine morphology	PRAMEF7 ZNF226 SLC12A5 OR1E1 OR1E2 CPLANE1 CNR2 FPR2 FPR3 PRAMEF12 PRAMEF8 SLC12A2 LOXL1	1.97e-05	276	162	13	MP:0000489
MousePheno	abnormal systemic artery morphology	TMEM67 MKS1 FREM2 GLA CPLANE1 DMXL2 NAT8 WDR27 ABCC9 FLVCR2 ODAD2 PIGV MEGF8	5.38e-05	304	162	13	MP:0011655
MousePheno	abnormal stomach position or orientation	TMEM67 MKS1 NAT8 ODAD2 MEGF8	5.54e-05	36	162	5	MP:0010807
MousePheno	right aortic arch	MKS1 FREM2 CPLANE1 ODAD2 PIGV MEGF8	6.59e-05	60	162	6	MP:0004158
MousePheno	abnormal aortic arch morphology	TMEM67 MKS1 FREM2 CPLANE1 ABCC9 ODAD2 PIGV MEGF8	7.22e-05	119	162	8	MP:0004113
MousePheno	abnormal fluid regulation	KMT2B SPTAN1 PECAM1 CHRM5 MKS1 HIRA SLC12A5 SLC35D1 PLAT LRRC7 CPLANE1 SLC27A4 DSC1 NAT8 GJC1 RICTOR HACD2 SLC5A3 SLC12A2 MEGF8 DISP1 GABBR1 FBXW7	8.00e-05	826	162	23	MP:0001784
MousePheno	double outlet right ventricle, ventricular defect committed to aorta	NAT8 ODAD2 MEGF8	1.22e-04	9	162	3	MP:0011666
MousePheno	semilobar holoprosencephaly	TMEM67 MKS1	1.33e-04	2	162	2	MP:0014278
MousePheno	abnormal blood vessel morphology	TMEM67 CYP2E1 ACTRT3 SPTAN1 PECAM1 ADAM10 MKS1 HIRA SLC12A5 FREM2 MFGE8 GLA PLAT PLAUR STRA6 CPLANE1 MFSD1 DMXL2 RIPK3 NAT8 WDR27 ABCC9 RICTOR FLVCR2 HACD2 ODAD2 PIGV PIKFYVE MEGF8 LOXL2 DISP1 FBXW7 CYB561	1.47e-04	1472	162	33	MP:0001614
MousePheno	abnormal thoracic aorta morphology	TMEM67 MKS1 FREM2 CPLANE1 ABCC9 ODAD2 PIGV MEGF8	1.66e-04	134	162	8	MP:0010468
MousePheno	abnormal lung morphology	PECAM1 CLEC7A CUL9 MKS1 SLC12A5 FREM2 HACE1 OR1E1 OR1E2 PLAT CPLANE1 GCN1 SLC27A4 NAT8 FLVCR2 ODAD2 SLC5A3 PIKFYVE MEGF8 LOXL1 FBXW7	2.12e-04	767	162	21	MP:0001175
Domain	AA-permease/SLC12A_dom	SLC12A5 SLC7A14 SLC7A4 SLC12A2 SLC12A4	3.86e-06	22	210	5	IPR004841
Domain	AA_permease	SLC12A5 SLC7A14 SLC7A4 SLC12A2 SLC12A4	3.86e-06	22	210	5	PF00324
Domain	WD40_repeat	WDR4 HIRA WDR38 RPTOR HERC1 DMXL2 VPS8 GEMIN5 WDR27 TEP1 SCAP PAFAH1B1 FBXW7	1.32e-05	272	210	13	IPR001680
Domain	WD_REPEATS_1	WDR4 HIRA WDR38 RPTOR HERC1 DMXL2 VPS8 GEMIN5 WDR27 TEP1 SCAP PAFAH1B1 FBXW7	1.66e-05	278	210	13	PS00678
Domain	WD_REPEATS_2	WDR4 HIRA WDR38 RPTOR HERC1 DMXL2 VPS8 GEMIN5 WDR27 TEP1 SCAP PAFAH1B1 FBXW7	1.73e-05	279	210	13	PS50082
Domain	WD_REPEATS_REGION	WDR4 HIRA WDR38 RPTOR HERC1 DMXL2 VPS8 GEMIN5 WDR27 TEP1 SCAP PAFAH1B1 FBXW7	1.73e-05	279	210	13	PS50294
Domain	WD40_repeat_dom	WDR4 HIRA WDR38 RPTOR HERC1 DMXL2 VPS8 GEMIN5 WDR27 TEP1 SCAP PAFAH1B1 FBXW7	3.32e-05	297	210	13	IPR017986
Domain	WD40	WDR4 HIRA WDR38 RPTOR HERC1 DMXL2 GEMIN5 WDR27 TEP1 SCAP PAFAH1B1 FBXW7	3.86e-05	259	210	12	PF00400
Domain	SLC12A_fam	SLC12A5 SLC12A2 SLC12A4	4.74e-05	7	210	3	IPR004842
Domain	WD40	WDR4 HIRA WDR38 RPTOR HERC1 DMXL2 GEMIN5 WDR27 TEP1 SCAP PAFAH1B1 FBXW7	5.38e-05	268	210	12	SM00320
Domain	SLC12_C	SLC12A5 SLC12A2 SLC12A4	7.53e-05	8	210	3	IPR018491
Domain	SLC12	SLC12A5 SLC12A2 SLC12A4	7.53e-05	8	210	3	PF03522
Domain	-	WDR4 HIRA WDR38 RPTOR HERC1 DMXL2 VPS8 GEMIN5 WDR27 TEP1 SCAP PAFAH1B1 FBXW7	1.06e-04	333	210	13	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	WDR4 HIRA WDR38 RPTOR HERC1 DMXL2 VPS8 GEMIN5 WDR27 TEP1 SCAP PAFAH1B1 FBXW7	1.13e-04	335	210	13	IPR015943
Domain	Hyaluronidase_PH20	HYAL4 SPAM1	1.26e-04	2	210	2	IPR001439
Domain	Ecm29/Gcn1	GCN1 ECPAS	1.26e-04	2	210	2	IPR026827
Domain	Formyl_pep_2/3_rcpt	FPR2 FPR3	1.26e-04	2	210	2	IPR027347
Domain	Formyl_rcpt-rel	FPR1 FPR2 FPR3	1.59e-04	10	210	3	IPR000826
Domain	GPCR_Rhodpsn_7TM	OR2L8 OR2L3 CHRM1 CHRM5 OR1E1 OR1E2 CNR2 OR10H5 GPR31 FPR1 FPR2 FPR3 OR10X1 OR4C15 OR10G2 OR10H2 OR10H1 OR4A16 OR2A2	2.11e-04	670	210	19	IPR017452
Domain	MFS	SLC22A8 SLC49A3 MFSD1 SLC2A8 FLVCR2 SLC16A5 SLC16A4	2.20e-04	108	210	7	PS50850
Domain	MFS_1	SLC22A8 SLC49A3 MFSD1 FLVCR2 SLC16A5 SLC16A4	2.30e-04	77	210	6	PF07690
Domain	MFS	SLC22A8 SLC49A3 MFSD1 FLVCR2 SLC16A5 SLC16A4	2.30e-04	77	210	6	IPR011701
Domain	7tm_1	OR2L8 OR2L3 CHRM1 CHRM5 OR1E1 OR1E2 CNR2 OR10H5 GPR31 FPR1 FPR2 FPR3 OR10X1 OR4C15 OR10G2 OR10H2 OR10H1 OR4A16 OR2A2	2.41e-04	677	210	19	PF00001
Domain	G_PROTEIN_RECEP_F1_1	OR2L8 OR2L3 CHRM1 CHRM5 OR1E1 OR1E2 CNR2 OR10H5 GPR31 FPR1 FPR2 FPR3 OR10X1 OR4C15 OR10G2 OR10H2 OR10H1 OR4A16 OR2A2	2.79e-04	685	210	19	PS00237
Domain	G_PROTEIN_RECEP_F1_2	OR2L8 OR2L3 CHRM1 CHRM5 OR1E1 OR1E2 CNR2 OR10H5 GPR31 FPR1 FPR2 FPR3 OR10X1 OR4C15 OR10G2 OR10H2 OR10H1 OR4A16 OR2A2	3.11e-04	691	210	19	PS50262
Domain	GPCR_Rhodpsn	OR2L8 OR2L3 CHRM1 CHRM5 OR1E1 OR1E2 CNR2 OR10H5 GPR31 FPR1 FPR2 FPR3 OR10X1 OR4C15 OR10G2 OR10H2 OR10H1 OR4A16 OR2A2	3.16e-04	692	210	19	IPR000276
Domain	Quinoprotein_ADH-like_supfam	EMC1 DMXL2 VPS8 GEMIN5 WDR27	3.17e-04	53	210	5	IPR011047
Domain	WD40_repeat_CS	HIRA WDR38 HERC1 GEMIN5 TEP1 SCAP PAFAH1B1 FBXW7	5.46e-04	164	210	8	IPR019775
Domain	Post-SET_dom	SETD1A KMT2B KMT2D	7.04e-04	16	210	3	IPR003616
Domain	PostSET	SETD1A KMT2B KMT2D	7.04e-04	16	210	3	SM00508
Domain	POST_SET	SETD1A KMT2B KMT2D	7.04e-04	16	210	3	PS50868
Domain	KCL_cotranspt	SLC12A5 SLC12A4	7.44e-04	4	210	2	IPR000076
Domain	MFS_dom	SLC22A8 SLC49A3 MFSD1 SLC2A8 FLVCR2 SLC16A5 SLC16A4	8.09e-04	134	210	7	IPR020846
Domain	PRAME_family	PRAMEF7 PRAMEF12 PRAMEF8	1.19e-03	19	210	3	IPR026271
Domain	Lysyl_oxidase	LOXL1 LOXL2	1.23e-03	5	210	2	IPR001695
Domain	FYrich_C	KMT2B KMT2D	1.23e-03	5	210	2	IPR003889
Domain	FYrich_N	KMT2B KMT2D	1.23e-03	5	210	2	IPR003888
Domain	CAT3	SLC7A14 SLC7A4	1.23e-03	5	210	2	IPR015606
Domain	FYRC	KMT2B KMT2D	1.23e-03	5	210	2	SM00542
Domain	FYRN	KMT2B KMT2D	1.23e-03	5	210	2	SM00541
Domain	AA_permease_C	SLC7A14 SLC7A4	1.23e-03	5	210	2	PF13906
Domain	LYSYL_OXIDASE	LOXL1 LOXL2	1.23e-03	5	210	2	PS00926
Domain	Musac_Ach_rcpt	CHRM1 CHRM5	1.23e-03	5	210	2	IPR000995
Domain	Lysyl_oxidase_CS	LOXL1 LOXL2	1.23e-03	5	210	2	IPR019828
Domain	Hyaluronidase	HYAL4 SPAM1	1.23e-03	5	210	2	IPR018155
Domain	CAT_C	SLC7A14 SLC7A4	1.23e-03	5	210	2	IPR029485
Domain	Glyco_hydro_56	HYAL4 SPAM1	1.23e-03	5	210	2	PF01630
Domain	FYRN	KMT2B KMT2D	1.23e-03	5	210	2	PF05964
Domain	FYRC	KMT2B KMT2D	1.23e-03	5	210	2	PF05965
Domain	FYRC	KMT2B KMT2D	1.23e-03	5	210	2	PS51543
Domain	FYRN	KMT2B KMT2D	1.23e-03	5	210	2	PS51542
Domain	Lysyl_oxidase	LOXL1 LOXL2	1.23e-03	5	210	2	PF01186
Domain	AAA	ABCA4 ABCC11 ABCC9 DNAH7 ATAD3A HELZ2 SNRNP200	1.23e-03	144	210	7	SM00382
Domain	AAA+_ATPase	ABCA4 ABCC11 ABCC9 DNAH7 ATAD3A HELZ2 SNRNP200	1.23e-03	144	210	7	IPR003593
Domain	Olfact_rcpt	OR2L8 OR2L3 OR1E1 OR1E2 OR10H5 OR10X1 OR4C15 OR10G2 OR10H2 OR10H1 OR4A16 OR2A2	1.70e-03	393	210	12	IPR000725
Domain	SET	SETD1A KMT2B PRDM8 KMT2D	1.75e-03	46	210	4	SM00317
Domain	EPHD	KMT2B KMT2D KDM4B	1.84e-03	22	210	3	PS51805
Domain	Spectrin	TRIO SPTAN1 KALRN	2.10e-03	23	210	3	PF00435
Domain	SET_dom	SETD1A KMT2B PRDM8 KMT2D	2.39e-03	50	210	4	IPR001214
Domain	SET	SETD1A KMT2B PRDM8 KMT2D	2.39e-03	50	210	4	PS50280
Pathway	REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS	SLC12A5 SLC12A2 SLC12A4	4.42e-05	7	155	3	M27339
Pathway	REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS	SLC12A5 SLC12A2 SLC12A4	4.42e-05	7	155	3	MM15081
Pathway	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT	SLC30A1 SLC12A5 SLC35D1 SLC22A8 SLC27A4 SLC2A8 SLC5A3 SLC5A4 SLC12A2 SLC12A4 SLC14A1	6.45e-05	238	155	11	MM15076
Pathway	REACTOME_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS	FPR1 FPR2 FPR3	7.01e-05	8	155	3	M27370
Pathway	REACTOME_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS	FPR1 FPR2 FPR3	7.01e-05	8	155	3	MM15110
Pathway	PID_UPA_UPAR_PATHWAY	FGA PLAUR FPR1 FPR2 FPR3	9.23e-05	42	155	5	M174
Pathway	REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT	SLC30A1 SLC12A5 SLC35D1 SLC22A8 SLC27A4 SLC2A8 SLC5A3 SLC5A4 SLC12A2 SLC12A4 SLC14A1	9.66e-05	249	155	11	M5988
Pathway	REACTOME_OLFACTORY_SIGNALING_PATHWAY	OR1E1 OR1E2 OR10H5 OR10X1 OR10H2 OR10H1	1.18e-04	70	155	6	MM14984
Pathway	WP_GPCRS_CLASS_A_RHODOPSINLIKE	CHRM1 CHRM5 OR1E1 OR1E2 CNR2 GPR31 FPR1 FPR2 FPR3 OR10H2 OR10H1	1.41e-04	260	155	11	M39397
Pathway	REACTOME_SENSORY_PERCEPTION	OR2L8 ABCA4 OR2L3 SPTAN1 OR1E1 OR1E2 STRA6 OR10H5 RBP3 EBF1 OR10X1 OR4C15 OR10G2 OR10H2 OR10H1 OR4A16 LHFPL5 OR2A2	2.18e-04	636	155	18	M41834
Pathway	REACTOME_SENSORY_PERCEPTION	ABCA4 OR1E1 OR1E2 STRA6 OR10H5 RBP3 OR10X1 OR10H2 OR10H1	2.52e-04	190	155	9	MM15687
Pubmed	Identification, cloning, and functional characterization of a murine lipoxin A4 receptor homologue gene.	FPR1 FPR2 FPR3	2.50e-07	3	220	3	12218158
Pubmed	Characterization of two new members of the formyl peptide receptor gene family from 129S6 mice.	FPR1 FPR2 FPR3	2.50e-07	3	220	3	12459252
Pubmed	Formyl peptide receptor 1 up-regulation and formyl peptide receptor 2/3 down-regulation of blood immune cells along with defective lipoxin A4/resolvin D1 production in obstructive sleep apnea patients.	FPR1 FPR2 FPR3	2.50e-07	3	220	3	31116781
Pubmed	International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.	FPR1 FPR2 FPR3	2.50e-07	3	220	3	19498085
Pubmed	Functional expression of formyl peptide receptor family in human NK cells.	FPR1 FPR2 FPR3	2.50e-07	3	220	3	19843937
Pubmed	Formyl peptide receptors from immune and vomeronasal system exhibit distinct agonist properties.	FPR1 FPR2 FPR3	2.50e-07	3	220	3	22859307
Pubmed	Phagocyte activation by Trp-Lys-Tyr-Met-Val-Met, acting through FPRL1/LXA4R, is not affected by lipoxin A4.	FPR1 FPR2 FPR3	2.50e-07	3	220	3	12410796
Pubmed	Formyl peptide receptor 2 is an emerging modulator of inflammation in the liver.	FPR1 FPR2 FPR3	2.50e-07	3	220	3	36750693
Pubmed	Formyl peptide receptor-like 2 is expressed and functional in plasmacytoid dendritic cells, tissue-specific macrophage subpopulations, and eosinophils.	FPR1 FPR2 FPR3	2.50e-07	3	220	3	19342677
Pubmed	Formyl peptide receptors are candidate chemosensory receptors in the vomeronasal organ.	FPR1 FPR2 FPR3	2.50e-07	3	220	3	19497865
Pubmed	Mouse screen reveals multiple new genes underlying mouse and human hearing loss.	TNIK TTC39B PRAMEF7 SETD1A ABCA4 MLEC MRM1 NHLRC2 TMC3 MKS1 HIRA YIPF1 NFKBIL1 HERC1 FKBP3 VWA5B1 DMXL2 RALGAPB PRAMEF12 PRAMEF8 CCDC57 SLC16A4 ATAD3A KDM4B CYB561	3.82e-07	1242	220	25	30973865
Pubmed	Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.	SPTAN1 MFGE8 FGA RBP3 SLC12A2 MAN1B1	7.54e-07	50	220	6	24769233
Pubmed	Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms.	FPR1 FPR2 FPR3	9.94e-07	4	220	3	12560218
Pubmed	An annexin 1 N-terminal peptide activates leukocytes by triggering different members of the formyl peptide receptor family.	FPR1 FPR2 FPR3	9.94e-07	4	220	3	15187149
Pubmed	Mapping of genes for the human C5a receptor (C5AR), human FMLP receptor (FPR), and two FMLP receptor homologue orphan receptors (FPRH1, FPRH2) to chromosome 19.	FPR1 FPR2 FPR3	9.94e-07	4	220	3	1612600
Pubmed	The N-formylpeptide receptor (FPR) and a second G(i)-coupled receptor mediate fMet-Leu-Phe-stimulated activation of NADPH oxidase in murine neutrophils.	FPR1 FPR2 FPR3	9.94e-07	4	220	3	12470609
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SETD1A KMT2B TRIO CUL9 HIRA RPTOR HERC1 GCN1 KALRN GEMIN5 CLDN4 TEP1 PIKFYVE KMT2D SCAP SLC12A4 SLC16A5 MEGF8 TLN1 TMEM268 HELZ2 ESPL1	2.38e-06	1105	220	22	35748872
Pubmed	Global genetic analysis in mice unveils central role for cilia in congenital heart disease.	TMEM67 FREM2 CPLANE1 NAT8 ODAD2 PIGV MEGF8	3.58e-06	100	220	7	25807483
Pubmed	The FBXW7-SHOC2-Raptor Axis Controls the Cross-Talks between the RAS-ERK and mTORC1 Signaling Pathways.	RPTOR RICTOR FBXW7	4.92e-06	6	220	3	30865892
Pubmed	Critical roles of mTORC1 signaling and metabolic reprogramming for M-CSF-mediated myelopoiesis.	RPTOR RICTOR SCAP	4.92e-06	6	220	3	28784627
Pubmed	Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1.	PECAM1 RPTOR RICTOR	8.58e-06	7	220	3	17141160
Pubmed	Similar effects of all WNK3 variants on SLC12 cotransporters.	SLC12A5 SLC12A2 SLC12A4	1.37e-05	8	220	3	21613606
Pubmed	The plasticity of WDR5 peptide-binding cleft enables the binding of the SET1 family of histone methyltransferases.	SETD1A KMT2B KMT2D	1.37e-05	8	220	3	22266653
Pubmed	Disruption of KCC2 reveals an essential role of K-Cl cotransport already in early synaptic inhibition.	SLC12A5 SLC12A2 SLC12A4	1.37e-05	8	220	3	11395011
Pubmed	Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases.	SETD1A KMT2B KMT2D	1.37e-05	8	220	3	23130995
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	TNIK GCN1 DMXL2 RALGAPB SCAP TLN1 HELZ2 SNRNP200 KDM4B	1.47e-05	225	220	9	12168954
Pubmed	Structural basis for WDR5 interaction (Win) motif recognition in human SET1 family histone methyltransferases.	SETD1A KMT2B KMT2D	2.04e-05	9	220	3	22665483
Pubmed	Localized LoxL3-Dependent Fibronectin Oxidation Regulates Myofiber Stretch and Integrin-Mediated Adhesion.	PECAM1 LOXL1 LOXL2	2.04e-05	9	220	3	26954549
Pubmed	Cation-chloride cotransporters and neuronal function.	SLC12A5 SLC12A2 SLC12A4	2.04e-05	9	220	3	19323993
Pubmed	Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse.	FPR1 FPR2 FPR3	2.04e-05	9	220	3	9722950
Pubmed	Dysbindin Deficiency Modifies the Expression of GABA Neuron and Ion Permeation Transcripts in the Developing Hippocampus.	GAD2 CHRM1 SLC12A5 SLC12A2	3.27e-05	29	220	4	28344592
Pubmed	Thirteen Ovary-Enriched Genes Are Individually Not Essential for Female Fertility in Mice.	PRAMEF7 PKD1L2 PRAMEF12 PRAMEF8	3.75e-05	30	220	4	38786026
Pubmed	mTORC1 activity is essential for erythropoiesis and B cell lineage commitment.	RPTOR RICTOR EBF1	3.97e-05	11	220	3	31729420
Pubmed	A CCR2 macrophage endocytic pathway mediates extravascular fibrin clearance in vivo.	FGA PLAT PLAUR	3.97e-05	11	220	3	26647393
Pubmed	Studies of the interactions between the anticytokeratin 8 monoclonal antibody TS1, its antigen and its anti-idiotypic antibody alphaTS1.	IGKV2D-28 IGKV2-28	3.98e-05	2	220	2	12833571
Pubmed	Abnormal expression of cerebrospinal fluid cation chloride cotransporters in patients with Rett syndrome.	SLC12A5 SLC12A2	3.98e-05	2	220	2	23894354
Pubmed	Two V kappa germ-line genes related to the GAT idiotypic network (Ab1 and Ab3/Ab1') account for the major subfamilies of the mouse V kappa-1 variability subgroup.	IGKV2D-28 IGKV2-28	3.98e-05	2	220	2	3100621
Pubmed	Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas.	PLAUR FPR1	3.98e-05	2	220	2	28465589
Pubmed	mTOR Directs Breast Morphogenesis through the PKC-alpha-Rac1 Signaling Axis.	RPTOR RICTOR	3.98e-05	2	220	2	26132202
Pubmed	N-formylpeptides induce two distinct concentration optima for mouse neutrophil chemotaxis by differential interaction with two N-formylpeptide receptor (FPR) subtypes. Molecular characterization of FPR2, a second mouse neutrophil FPR.	FPR1 FPR2	3.98e-05	2	220	2	10477558
Pubmed	The presence of m1 to m5 receptors in human sclera: evidence of the sclera as a potential site of action for muscarinic receptor antagonists.	CHRM1 CHRM5	3.98e-05	2	220	2	16877267
Pubmed	Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2.	FPR1 FPR2	3.98e-05	2	220	2	35217703
Pubmed	The non-steroidal anti-inflammatory drug piroxicam blocks ligand binding to the formyl peptide receptor but not the formyl peptide receptor like 1.	FPR1 FPR2	3.98e-05	2	220	2	17692291
Pubmed	NKCC1 and KCC2 prevent hyperexcitability in the mouse hippocampus.	SLC12A5 SLC12A2	3.98e-05	2	220	2	18394864
Pubmed	Mitocryptide-2: Identification of Its Minimum Structure for Specific Activation of FPR2-Possible Receptor Switching from FPR2 to FPR1 by Its Physiological C-terminal Cleavages.	FPR1 FPR2	3.98e-05	2	220	2	33920954
Pubmed	Structural and affinity studies of IgM polyreactive natural autoantibodies.	IGKV2D-28 IGKV2-28	3.98e-05	2	220	2	8993018
Pubmed	KCC2 expression supersedes NKCC1 in mature fiber cells in mouse and rabbit lenses.	SLC12A5 SLC12A2	3.98e-05	2	220	2	26539026
Pubmed	Differential expression of the G-protein-coupled formyl Peptide receptor in melanoma associates with aggressive phenotype.	FPR1 FPR2	3.98e-05	2	220	2	23147350
Pubmed	A neutrophil inhibitory pepducin derived from FPR1 expected to target FPR1 signaling hijacks the closely related FPR2 instead.	FPR1 FPR2	3.98e-05	2	220	2	26071379
Pubmed	Interpreting an apoptotic corpse as anti-inflammatory involves a chloride sensing pathway.	SLC12A2 SLC12A4	3.98e-05	2	220	2	31792382
Pubmed	Aspirin-triggered 15-epi-lipoxin A4 (LXA4) and LXA4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors.	FPR2 FPR3	3.98e-05	2	220	2	9151906
Pubmed	NKCC1 transporter facilitates seizures in the developing brain.	SLC12A5 SLC12A2	3.98e-05	2	220	2	16227993
Pubmed	Kabuki syndrome stem cell models reveal locus specificity of histone methyltransferase 2D (KMT2D/MLL4).	KMT2B KMT2D	3.98e-05	2	220	2	35640156
Pubmed	Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4).	FPR2 FPR3	3.98e-05	2	220	2	12172542
Pubmed	Lipoxin A4 inhibits the production of proinflammatory cytokines induced by β-amyloid in vitro and in vivo.	FPR2 FPR3	3.98e-05	2	220	2	21501589
Pubmed	A Critical Role of Formyl Peptide Receptors in Host Defense against Escherichia coli.	FPR1 FPR2	3.98e-05	2	220	2	32221037
Pubmed	Analysis of CD8+ T cell-mediated anti-viral responses in mice with targeted deletions of the M1 or M5 muscarinic cholinergic receptors.	CHRM1 CHRM5	3.98e-05	2	220	2	17286988
Pubmed	Intracellular formyl peptide receptor regulates naïve CD4 T cell migration.	FPR1 FPR3	3.98e-05	2	220	2	29427663
Pubmed	The chloride co-transporters, NKCC1 and KCC2, in experimental autoimmune encephalomyelitis (EAE).	SLC12A5 SLC12A2	3.98e-05	2	220	2	28057537
Pubmed	G-protein-coupled formyl peptide receptors play a dual role in neutrophil chemotaxis and bacterial phagocytosis.	FPR1 FPR2	3.98e-05	2	220	2	30540534
Pubmed	The structural basis of function and regulation of neuronal cotransporters NKCC1 and KCC2.	SLC12A5 SLC12A2	3.98e-05	2	220	2	33597714
Pubmed	Repeated stress-induced expression pattern alterations of the hippocampal chloride transporters KCC2 and NKCC1 associated with behavioral abnormalities in female mice.	SLC12A5 SLC12A2	3.98e-05	2	220	2	26239662
Pubmed	Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor.	FPR1 FPR2	3.98e-05	2	220	2	23686496
Pubmed	V genes of oxazolone antibodies in 10 strains of mice.	IGKV2D-28 IGKV2-28	3.98e-05	2	220	2	1936125
Pubmed	A vasculo-protective circuit centered on lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation.	FPR2 FPR3	3.98e-05	2	220	2	23733341
Pubmed	Diminished antigen-specific IgG1 and interleukin-6 production and acetylcholinesterase expression in combined M1 and M5 muscarinic acetylcholine receptor knockout mice.	CHRM1 CHRM5	3.98e-05	2	220	2	17586055
Pubmed	NKCC1 cotransporter inactivation underlies embryonic development of chloride-mediated inhibition in mouse spinal motoneuron.	SLC12A5 SLC12A2	3.98e-05	2	220	2	18096599
Pubmed	Reversing excitatory GABAAR signaling restores synaptic plasticity and memory in a mouse model of Down syndrome.	SLC12A5 SLC12A2	3.98e-05	2	220	2	25774849
Pubmed	Formyl peptide receptors promotes neural differentiation in mouse neural stem cells by ROS generation and regulation of PI3K-AKT signaling.	FPR1 FPR2	3.98e-05	2	220	2	28303030
Pubmed	Differential expression of members of the N-formylpeptide receptor gene cluster in human phagocytes.	FPR2 FPR3	3.98e-05	2	220	2	8198572
Pubmed	A structural homologue of the N-formyl peptide receptor. Characterization and chromosome mapping of a peptide chemoattractant receptor family.	FPR1 FPR2	3.98e-05	2	220	2	1373134
Pubmed	Nucleotide sequences of the variable regions of a mouse monoclonal antibody MRK16.	IGKV2D-28 IGKV2-28	3.98e-05	2	220	2	2110659
Pubmed	Formylpeptide receptors mediate rapid neutrophil mobilization to accelerate wound healing.	FPR1 FPR2	3.98e-05	2	220	2	24603667
Pubmed	Hypoxia-inducible factors in CD4+ T cells promote metabolism, switch cytokine secretion, and T cell help in humoral immunity.	RPTOR RICTOR	3.98e-05	2	220	2	30988188
Pubmed	Long-term expressional changes of Na+ -K+ -Cl- co-transporter 1 (NKCC1) and K+ -Cl- co-transporter 2 (KCC2) in CA1 region of hippocampus following lithium-pilocarpine induced status epilepticus (PISE).	SLC12A5 SLC12A2	3.98e-05	2	220	2	18550034
Pubmed	[Expression of cation chloride cotransporter (NKCC1/KCC2) in brain tissue of children with focal cortical dysplasia type Ⅱ].	SLC12A5 SLC12A2	3.98e-05	2	220	2	36323541
Pubmed	Human cytomegalovirus infection alters the substrate specificities and rapamycin sensitivities of raptor- and rictor-containing complexes.	RPTOR RICTOR	3.98e-05	2	220	2	16959881
Pubmed	Regulation of endothelial cell proliferation and vascular assembly through distinct mTORC2 signaling pathways.	RPTOR RICTOR	3.98e-05	2	220	2	25582201
Pubmed	Reversal of β-Amyloid-Induced Microglial Toxicity In Vitro by Activation of Fpr2/3.	FPR2 FPR3	3.98e-05	2	220	2	32617132
Pubmed	Ciliary and centrosomal defects associated with mutation and depletion of the Meckel syndrome genes MKS1 and MKS3.	TMEM67 MKS1	3.98e-05	2	220	2	19515853
Pubmed	Kalirin and Trio proteins serve critical roles in excitatory synaptic transmission and LTP.	TRIO KALRN	3.98e-05	2	220	2	26858404
Pubmed	Adipocyte mTORC1 deficiency promotes adipose tissue inflammation and NLRP3 inflammasome activation via oxidative stress and de novo ceramide synthesis.	RPTOR RICTOR	3.98e-05	2	220	2	28679588
Pubmed	Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis.	LOXL1 LOXL2	3.98e-05	2	220	2	29125826
Pubmed	A critical role for Rictor in T lymphopoiesis.	RPTOR RICTOR	3.98e-05	2	220	2	22815285
Pubmed	N-Formylated humanin activates both formyl peptide receptor-like 1 and 2.	FPR2 FPR3	3.98e-05	2	220	2	15465011
Pubmed	Resolvin D1 protects the liver from ischemia/reperfusion injury by enhancing M2 macrophage polarization and efferocytosis.	FPR2 FPR3	3.98e-05	2	220	2	27317426
Pubmed	The urokinase receptor takes control of cell migration by recruiting integrins and FPR1 on the cell surface.	PLAUR FPR1	3.98e-05	2	220	2	24466048
Pubmed	Formylpeptide receptor 1 contributes to epidermal barrier dysfunction-induced skin inflammation through NOD-like receptor C4-dependent keratinocyte activation.	NLRC4 FPR1	3.98e-05	2	220	2	37979162
Pubmed	N-formyl peptide receptor 3 (FPR3) departs from the homologous FPR2/ALX receptor with regard to the major processes governing chemoattractant receptor regulation, expression at the cell surface, and phosphorylation.	FPR2 FPR3	3.98e-05	2	220	2	21543323
Pubmed	Spectrum of MKS1 and MKS3 mutations in Meckel syndrome: a genotype-phenotype correlation. Mutation in brief #960. Online.	TMEM67 MKS1	3.98e-05	2	220	2	17397051
Pubmed	Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator.	PLAT PLAUR	3.98e-05	2	220	2	8650190
Pubmed	Opposite effect of membrane raft perturbation on transport activity of KCC2 and NKCC1.	SLC12A5 SLC12A2	3.98e-05	2	220	2	19686239
Pubmed	Raptor and rictor expression in patients with human papillomavirus-related oropharyngeal squamous cell carcinoma.	RPTOR RICTOR	3.98e-05	2	220	2	33482765
Pubmed	Different Role of Raptor and Rictor in Regulating Rasfonin-Induced Autophagy and Apoptosis in Renal Carcinoma Cells.	RPTOR RICTOR	3.98e-05	2	220	2	33155352
Pubmed	NKCC1 to KCC2 mRNA Ratio in Schizophrenia and Its Psychopathology: a Case-Control Study.	SLC12A5 SLC12A2	3.98e-05	2	220	2	35624355
Pubmed	Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses.	FPR2 FPR3	3.98e-05	2	220	2	17084101
Pubmed	Localization of the binding site of tissue-type plasminogen activator to fibrin.	FGA PLAT	3.98e-05	2	220	2	3088041
Pubmed	Strain-specific Loss of Formyl Peptide Receptor 3 in the Murine Vomeronasal and Immune Systems.	FPR2 FPR3	3.98e-05	2	220	2	26957543
Pubmed	Permissive proteolytic activity for visual cortical plasticity.	GAD2 PLAT	3.98e-05	2	220	2	12032349
Pubmed	Cryoglobulinemia induced by a murine IgG3 rheumatoid factor: skin vasculitis and glomerulonephritis arise from distinct pathogenic mechanisms.	IGKV2D-28 IGKV2-28	3.98e-05	2	220	2	2263605
GeneFamily	Solute carriers	SLC25A34 SLC30A1 SLC12A5 SLC35D1 SLC22A8 SLC49A3 SLC27A4 SLC25A41 SLC2A8 FLVCR2 SLC7A14 SLC5A3 SLC5A4 SLC7A4 SLC12A2 SLC12A4 SLC16A5 SLC16A4 SLC14A1	2.01e-09	395	159	19	752
GeneFamily	Formyl peptide receptors	FPR1 FPR2 FPR3	6.67e-07	3	159	3	198
GeneFamily	WD repeat domain containing	WDR4 HIRA WDR38 RPTOR HERC1 DMXL2 GEMIN5 WDR27 TEP1 SCAP PAFAH1B1 FBXW7	3.60e-06	262	159	12	362
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	SETD1A KMT2B PRDM8 KMT2D	2.17e-04	34	159	4	487
GeneFamily	Olfactory receptors, family 10	OR10H5 OR10X1 OR10G2 OR10H2 OR10H1	2.86e-04	66	159	5	157
GeneFamily	Cholinergic receptors muscarinic	CHRM1 CHRM5	7.55e-04	5	159	2	180
GeneFamily	PRAME family	PRAMEF7 PRAMEF12 PRAMEF8	1.18e-03	24	159	3	686
GeneFamily	Dolichyl D-mannosyl phosphate dependent mannosyltransferases\|Phosphatidylinositol glycan anchor biosynthesis	PIGV PIGZ	2.66e-03	9	159	2	430
Coexpression	MILI_PSEUDOPODIA_HAPTOTAXIS_DN	SETD1A EMC1 KMT2B MLEC TRIO NHLRC2 DNAJC22 SLC30A1 MFGE8 GLA TM9SF2 MFSD1 SLC27A4 GJC1 HACD2 TMEM101 SLC12A4 TLN1 HELZ2	3.85e-06	681	215	19	M5314
Coexpression	MILI_PSEUDOPODIA_HAPTOTAXIS_DN	SETD1A EMC1 KMT2B MLEC TRIO NHLRC2 DNAJC22 SLC30A1 MFGE8 GLA TM9SF2 MFSD1 SLC27A4 GJC1 HACD2 TMEM101 SLC12A4 TLN1 HELZ2	6.06e-06	703	215	19	MM1055
Coexpression	NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR	ADAM10 MFGE8 HMCN1 MEGF8 LOXL1 LOXL2	8.91e-06	59	215	6	M47989
Coexpression	MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN	IL36B PLAUR FPR2 FPR3	1.55e-05	19	215	4	MM773
CoexpressionAtlas	Myeloid Cells, MF.Lu, CD11chi CD11b- CD103- MHCII- SiglecF+, Lung, avg-3	CLEC7A PLAUR MRC1 DMXL2 FPR1 FLVCR2 MCOLN3	1.48e-05	83	203	7	GSM538282_100
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA4 PKD1L2 CHRM1 GALNT13 FREM2 KALRN ODAD2 HMCN1 EPHA5	3.40e-07	184	219	9	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA4 PKD1L2 CHRM1 GALNT13 FREM2 KALRN ODAD2 HMCN1 EPHA5	3.40e-07	184	219	9	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA4 PKD1L2 CHRM1 GALNT13 FREM2 KALRN ODAD2 HMCN1 EPHA5	3.40e-07	184	219	9	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	(3)_Macrophage_MARCOpos\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	CLEC7A GCHFR NFKBIL1 TSPO SLC49A3 MFSD1 MRC1 FPR3 FLVCR2	4.87e-07	192	219	9	b1e2175bd4c02106e52d8f491eea1329ac327ae9
ToppCell	Macrophages-SSc-ILD_02\|World / lung cells shred on cell class, cell subclass, sample id	CLEC7A GCHFR HP NFKBIL1 TSPO PLAUR MRC1 FPR1 FPR2	5.08e-07	193	219	9	18534bd60bdd1ce51f948380c78017679931b8b1
ToppCell	(7)_Monocyte\|World / Spleen cell shreds - cell class (v1) and cell subclass (v1)	CLEC7A NLRC4 HP NFKBIL1 TSPO PLAUR DMXL2 FPR1 FPR2	5.78e-07	196	219	9	0232167559dcd2d86ee8b78017cf5f2a084b2cb7
ToppCell	Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CLEC7A GCHFR NLRC4 TSPO PLAUR MRC1 DMXL2 FPR2 FLVCR2	6.30e-07	198	219	9	ab70bf89690410221ec7aa3149bb50ac34433f99
ToppCell	proximal-3-Hematologic-Alveolar_Macrophage\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PECAM1 CLEC7A GCHFR NLRC4 HP MRC1 FPR1 FPR2 FLVCR2	6.30e-07	198	219	9	a5daf11bf7fe614be9f4a0fc6a4b37b5dce2f6fc
ToppCell	proximal-Hematologic-Alveolar_Macrophage-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PECAM1 CLEC7A GCHFR NLRC4 HP MRC1 FPR1 FPR2 FLVCR2	6.30e-07	198	219	9	a5deecd8809bc5b38ffda02143598ad0145e2559
ToppCell	proximal-Hematologic-Alveolar_Macrophage\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PECAM1 CLEC7A GCHFR NLRC4 HP MRC1 FPR1 FPR2 FLVCR2	6.30e-07	198	219	9	ec0092ef6207e788e2c20ddf007a2f6f6e351d0b
ToppCell	COVID-19-Myeloid-Alveolar_macrophages\|COVID-19 / group, cell type (main and fine annotations)	CLEC7A GCHFR TSPO PLAUR MFSD1 MRC1 DMXL2 FPR3 FLVCR2	6.57e-07	199	219	9	e1c85ca85fa22c4a4fa1bbdf55304bf3628485ee
ToppCell	Bronchial-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SLC25A34 CLEC7A TSPO PLAUR MFSD1 MRC1 FPR1 FPR2 FLVCR2	6.57e-07	199	219	9	a1ff1063741f6e5569feb44245785c9f472799b2
ToppCell	Parenchyma_COVID-19-Immune-TX-TRAM-2\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	PAG1 CLEC7A GCHFR NLRC4 TSPO PLAUR MRC1 FPR1 FPR2	6.57e-07	199	219	9	5e4f02cfb90912e83257ed20f69c12650d28619e
ToppCell	Lung_Parenchyma-Severe-Myeloid-TRAM-TRAM\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	PAG1 CLEC7A GCHFR NLRC4 TSPO PLAUR MRC1 FPR1 FPR2	6.85e-07	200	219	9	196dd7a90f6f334496997af0375e7a2c86f9a197
ToppCell	Bronchial-10x5prime-Immune_Myeloid\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CLEC7A GCHFR TSPO PLAUR MFSD1 MRC1 DMXL2 FPR1 FPR3	6.85e-07	200	219	9	d97e9253df98cf6ad3ef4fb28e344ec108d02b1e
ToppCell	Biopsy_Control_(H.)-Immune-Macrophages\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	CLEC7A GCHFR TSPO PLAUR MFSD1 MRC1 FPR1 FPR2 FPR3	6.85e-07	200	219	9	ad4c23e51bd34f5c515ce759a373ea431368a16e
ToppCell	Lung_Parenchyma-Severe-Myeloid-TRAM\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	PAG1 CLEC7A GCHFR NLRC4 TSPO PLAUR MRC1 FPR1 FPR2	6.85e-07	200	219	9	5e6f965f7b1323f1309543f44335d519996dfc1e
ToppCell	Bronchial-NucSeq-Immune_Myeloid\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PAG1 PECAM1 CLEC7A PLAUR MRC1 DMXL2 FPR1 FPR3 FLVCR2	6.85e-07	200	219	9	2f5b71e55c2de0e77fdae6667eb57f333acc6cd1
ToppCell	Lung_Parenchyma-Severe-Myeloid-TRAM-TRAM-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	PAG1 CLEC7A GCHFR NLRC4 TSPO PLAUR MRC1 FPR1 FPR2	6.85e-07	200	219	9	18f1415cfc718beffd91fb9f643cced2eefbca8d
ToppCell	Biopsy_Other_PF-Immune-Macrophages\|Biopsy_Other_PF / Sample group, Lineage and Cell type	CLEC7A GCHFR TSPO PLAUR MFSD1 MRC1 FPR1 FPR2 FPR3	6.85e-07	200	219	9	9ff5f0371aac2ab528b581fe979a1522579b8b84
ToppCell	Serous\|World / shred by cell class for turbinate	TTYH1 CHRM1 HP GPAT2 EBF1 SLC12A2 SLC14A1 FAM87A	8.06e-07	150	219	8	6a326662d58b0f17d6efa8cc28571f4cbbf57c2d
ToppCell	facs-Liver-Non-hepatocytes-3m-Myeloid-Kupffer_cell\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPAM1 ABCA4 NLRC4 FPR1 PLPP7 CLDN4 RNF17 MEGF8	8.91e-07	152	219	8	b61d2f6ee819c8dd4b4b601a8bc8388b1983de58
ToppCell	PND07-28-samps-Myeloid-Macrophage-macrophage-B\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	PAG1 CLEC7A PLAUR MRC1 DMXL2 FPR1 FPR2 FLVCR2	1.31e-06	160	219	8	694bf1f1952bd8ab444819f533da24fa2b73f701
ToppCell	CV-Severe-7\|Severe / Virus stimulation, Condition and Cluster	PAG1 ACTRT3 ADAM10 ZRANB3 KALRN HACD2 TBCK IGSF9B	2.79e-06	177	219	8	82fdd6185b368f54f03de389427cbe3071d21a99
ToppCell	PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAG1 GALNS PKD1L2 ARL5A GCN1 NUP160 DMXL2 RNF17	2.79e-06	177	219	8	1d5a071157c755f3a27a5c3143015da04ee0b0dc
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANKRD13B CHRM5 STRA6 HMCN1 LOXL1 LOXL2 SYT14 CERCAM	3.16e-06	180	219	8	935c091bbcd6d10b81dc4731779e5bd98205c99f
ToppCell	5'-Airway_Nasal-Mesenchymal\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANKRD13B CHRM5 STRA6 HMCN1 LOXL1 LOXL2 SYT14 CERCAM	3.16e-06	180	219	8	3dd384b7f3d9582b8fec9fe05100e466e6218b76
ToppCell	E18.5-samps-Mesenchymal-Pericyte\|E18.5-samps / Age Group, Lineage, Cell class and subclass	PAG1 MFGE8 HACE1 PLAT HRCT1 GJC1 ABCC9 EBF1	3.16e-06	180	219	8	0b1d370db64862fe1c7ea0ffaf06d03ec82e6e70
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CHRM5 ALDH1L2 STRA6 HMCN1 LOXL1 LOXL2 SYT14 CERCAM	3.57e-06	183	219	8	803376f5260de83c48d4f7301278d078a32b3e6e
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CHRM5 ALDH1L2 STRA6 HMCN1 LOXL1 LOXL2 SYT14 CERCAM	3.57e-06	183	219	8	6d98973098c6d20c5305bce6a83a549a7d8dbfba
ToppCell	5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CHRM5 ALDH1L2 STRA6 HMCN1 LOXL1 LOXL2 SYT14 CERCAM	3.57e-06	183	219	8	cc7f5a17b40e8d901885174922e5fa8877643071
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ANKRD13B PAG1 CYP2E1 SLC22A8 VPS8 ABCC9 ATAD3A EPHA5	3.72e-06	184	219	8	a6dee97ee4ef9d89e11d17339e0dadaea1210ce5
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Alveolar_Macrophage\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLEC7A ADARB1 MRC1 DMXL2 FPR1 FPR2 FLVCR2 MCOLN3	3.87e-06	185	219	8	775b72319ef6acffd2c9a74293b9c1bccea33f42
ToppCell	RV-07._Pericyte\|RV / Chamber and Cluster_Paper	PAG1 MFGE8 GPAT2 KALRN GJC1 ABCC9 EBF1 SLC12A2	4.03e-06	186	219	8	c533b264fbe12bc35467486fc7fbde24ba968fe1
ToppCell	RV-07._Pericyte\|World / Chamber and Cluster_Paper	PAG1 MFGE8 GPAT2 KALRN GJC1 ABCC9 EBF1 SLC12A2	4.19e-06	187	219	8	dc274d6bbda619a2c914d84e2b4069cfef1739d1
ToppCell	droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PAG1 CLEC7A ADARB1 MRC1 DMXL2 FPR1 FPR2 FLVCR2	4.53e-06	189	219	8	b2542b6fcf7bc10d29158d42b03182a939ff135a
ToppCell	droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage\|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PAG1 CLEC7A ADARB1 MRC1 DMXL2 FPR1 FPR2 FLVCR2	4.71e-06	190	219	8	da58227565ad6a690828dd8554dd3670222f8582
ToppCell	E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PAG1 MFGE8 PLAT RIPK3 GJC1 ABCC9 EBF1 SLC12A2	4.71e-06	190	219	8	84fbd5664ec886120963d4f50dfa1fd1851d36c1
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAG1 MFGE8 PLAT HRCT1 GJC1 ABCC9 EBF1 LOXL2	4.71e-06	190	219	8	951e067d14412db67dc3babcdf61e41717d7b429
ToppCell	Control-Myeloid\|Control / group, cell type (main and fine annotations)	PAG1 PECAM1 CLEC7A MFSD1 MRC1 DMXL2 FPR1 FPR3	4.90e-06	191	219	8	9c4acc5f3c2f9c0c5520863bb22f391774372347
ToppCell	Immune-alveolar_macrophage_(MARCO_positive)\|World / Lineage, Cell type, age group and donor	CLEC7A GCHFR TSPO PLAUR MRC1 DMXL2 FPR3 FLVCR2	5.70e-06	195	219	8	f92114ef995e690a3bedc62c89c5fd6773d0d9f7
ToppCell	3'_v3-Lung\|World / Manually curated celltypes from each tissue	CLEC7A GCHFR TSPO PLAUR MRC1 FPR1 FPR2 FLVCR2	5.92e-06	196	219	8	a04f8384b734ce67ec402e64bd891a6274f04744
ToppCell	(3)_MNP\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	CLEC7A NFKBIL1 TSPO PLAUR MFSD1 MRC1 FPR1 FPR3	5.92e-06	196	219	8	c79403da5443710a6caf035a279e42bc324b27c9
ToppCell	(7)_MNP-(7)_Monocyte\|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1)	PECAM1 HP NFKBIL1 TSPO PLAUR DMXL2 FPR1 FPR2	5.92e-06	196	219	8	4c2ea16352ba3482c02c03866460e0d975f9fc99
ToppCell	Bronchial-10x5prime-Stromal-Mesofibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CPA4 EPHB6 DNAJC22 SLC30A1 HP SLC25A41 LHFPL5 EPHA5	6.14e-06	197	219	8	438de7f0d35d81d5f5e41dcef7b2c54b6da03df4
ToppCell	COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CLEC7A NLRC4 PLAUR MFSD1 MRC1 DMXL2 FPR3 FLVCR2	6.14e-06	197	219	8	e42910a653a1b5bd90c090e9665a84871ed2873f
ToppCell	Bronchial-10x5prime-Stromal-Mesofibroblastic-Mesothelia\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CPA4 EPHB6 DNAJC22 SLC30A1 HP SLC25A41 LHFPL5 EPHA5	6.14e-06	197	219	8	26888af95a7cc082a1f1218af35b1f07cb9436ed
ToppCell	medial-Hematologic-Alveolar_Macrophage\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CLEC7A GCHFR HP PLAUR MRC1 FPR1 FPR2 FLVCR2	6.38e-06	198	219	8	8a21f885d26959b349eb4ca027328d6cf0f1b9cf
ToppCell	medial-Hematologic-Alveolar_Macrophage-2\|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CLEC7A GCHFR HP PLAUR MRC1 FPR1 FPR2 FLVCR2	6.38e-06	198	219	8	d64f3d806594619607a72025a93b43ed4efaed01
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MRM1 SLC25A34 CLEC7A PLAUR MFSD1 MRC1 HRCT1 PLPP7	6.38e-06	198	219	8	2b724d2a36843801984d46a969d33149b76c9771
ToppCell	medial-2-Hematologic-Alveolar_Macrophage\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CLEC7A GCHFR HP PLAUR MRC1 FPR1 FPR2 FLVCR2	6.38e-06	198	219	8	ad8b9ac155737f794bf1974c59f8143c6ef63d71
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	CLEC7A PLAUR MFSD1 MRC1 DMXL2 FPR1 FPR3 FLVCR2	6.38e-06	198	219	8	0b41b3d6c2db795320e8b65d40d85fb8b618cc34
ToppCell	(4)_Monocyte\|World / shred on Cell_type and subtype	CLEC7A NLRC4 HP NFKBIL1 PLAUR DMXL2 FPR1 FPR2	6.38e-06	198	219	8	56f9ebf902fe81c590696ba4c88028deaf346841
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CLEC7A GCHFR TSPO PLAUR MFSD1 MRC1 FPR2 FPR3	6.62e-06	199	219	8	94308fa48d73bedbfaf0e68570e151af26563b01
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PECAM1 CLEC7A TSPO PLAUR MRC1 DMXL2 FPR2 FPR3	6.62e-06	199	219	8	87956fcb39c2e3e99622ff05f99267d7621a78fc
ToppCell	Mild-Myeloid-Macrophages-FCN1+SPP1+\|Mild / Condition, Lineage, Cell class and cell subclass	PECAM1 CLEC7A PLAUR MFSD1 MRC1 DMXL2 FPR1 FPR3	6.62e-06	199	219	8	2cbaef86af870a228cb46895dd765ea8894c83c5
ToppCell	Parenchymal-NucSeq-Immune_Myeloid\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PAG1 PECAM1 CLEC7A NLRC4 PLAUR MRC1 FPR3 FLVCR2	6.62e-06	199	219	8	7ee2805fd9143eba11bf6832267b62189683608b
ToppCell	Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CLEC7A GCHFR PLAUR MFSD1 MRC1 DMXL2 FPR3 FLVCR2	6.62e-06	199	219	8	22001aa733273e784051b7f750e07d99aaf7a225
ToppCell	Parenchyma_Control_(B.)-Immune-TX\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	PAG1 CLEC7A GCHFR TSPO PLAUR MRC1 FPR1 FPR2	6.86e-06	200	219	8	a39886fd2decc81fb698dfd58da996f823bba417
ToppCell	Sigmoid-(4)_Monocyte\|Sigmoid / shred on region, Cell_type, and subtype	CLEC7A NLRC4 HP PLAUR DMXL2 FPR1 FPR2 HRCT1	6.86e-06	200	219	8	7f3920a0434d5199c6c8f0b3064a305bb0d87b60
ToppCell	Lung_Parenchyma-Control-Myeloid\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	PAG1 CLEC7A GCHFR TSPO PLAUR MRC1 FPR1 FPR2	6.86e-06	200	219	8	3a69149055ac8511eb789dbcc89fd17ccfb2ea6b
ToppCell	Sigmoid-Monocyte-Monocyte\|Sigmoid / Region, Cell class and subclass	CLEC7A NLRC4 HP PLAUR DMXL2 FPR1 FPR2 HRCT1	6.86e-06	200	219	8	010ca36970cb8894bdbca08779c0ecf56be22fc9
ToppCell	mLN-Macrophage\|mLN / Region, Cell class and subclass	CLEC7A NLRC4 PLAUR MRC1 DMXL2 FPR1 FPR2 FPR3	6.86e-06	200	219	8	68d709afd226241e002dae6d6820bccd1cfd87a1
ToppCell	COVID-19-Myeloid\|COVID-19 / Condition, Lineage and Cell class	CLEC7A TSPO PLAUR MFSD1 MRC1 DMXL2 FPR1 FPR3	6.86e-06	200	219	8	4c9e936b5e100c1a3ef10ea262febccf8226df9f
ToppCell	Sigmoid-Monocyte\|Sigmoid / Region, Cell class and subclass	CLEC7A NLRC4 HP PLAUR DMXL2 FPR1 FPR2 HRCT1	6.86e-06	200	219	8	c41bd6ec0f2262fce5cadb37a400d487e6662f49
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate\|5w / Sample Type, Dataset, Time_group, and Cell type.	SETD1A GAD2 TRIO SPTAN1 MEGF8 PAFAH1B1 LHFPL5 KDM4B	6.86e-06	200	219	8	c92e4fc0442404481fcac623d691dae6215b852d
ToppCell	Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macro_CCL\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	GCHFR PLAUR MRC1 DMXL2 FPR1 FPR2 FPR3 ESPL1	6.86e-06	200	219	8	db7acee26a02c0836923b0a92174f65c51fafab1
ToppCell	Sigmoid-(4)_Monocyte-(40)_Monocyte\|Sigmoid / shred on region, Cell_type, and subtype	CLEC7A NLRC4 HP PLAUR DMXL2 FPR1 FPR2 HRCT1	6.86e-06	200	219	8	576c0a1098e6a934448705de3673ef798fcf1b26
ToppCell	Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	CLEC7A SLC12A5 PLAUR MFSD1 MRC1 DMXL2 FPR1 FPR3	6.86e-06	200	219	8	1a080564de59abd59d3208a73441b6346e1c7cd8
ToppCell	normal_Pleural_Fluid-Myeloid_cells-Pleural_Mac\|normal_Pleural_Fluid / Location, Cell class and cell subclass	CLEC7A TSPO PLAUR MFSD1 MRC1 DMXL2 FPR1 FPR3	6.86e-06	200	219	8	1798eb621dccb4ccae18d9b3df558a6428d30542
ToppCell	mLN-(6)_Macrophage-(61)_LYVE1_Macrophage\|mLN / shred on region, Cell_type, and subtype	CLEC7A NLRC4 PLAUR MRC1 DMXL2 FPR1 FPR2 FPR3	6.86e-06	200	219	8	a20f5ec61d492d8a2adf695ec304b5d57296aa8f
ToppCell	mLN-Macrophage-LYVE1_Macrophage\|mLN / Region, Cell class and subclass	CLEC7A NLRC4 PLAUR MRC1 DMXL2 FPR1 FPR2 FPR3	6.86e-06	200	219	8	89cf739a3c2f5d30e547404f2f2ec6500cd1d65d
ToppCell	mLN-(6)_Macrophage\|mLN / shred on region, Cell_type, and subtype	CLEC7A NLRC4 PLAUR MRC1 DMXL2 FPR1 FPR2 FPR3	6.86e-06	200	219	8	6dcba82a7d322102bae205543086e84c7655b3e0
ToppCell	Parenchymal-10x5prime-Immune_Myeloid\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CLEC7A GCHFR TSPO PLAUR MFSD1 MRC1 DMXL2 FPR1	6.86e-06	200	219	8	d5b26580c84a7c942407786a67b20027986679fc
ToppCell	Parenchymal-10x5prime-Immune_Myeloid-Macrophage_alveolar-Macro_alv_MT\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CLEC7A GCHFR NLRC4 PLAUR MRC1 FPR1 FPR2 FPR3	6.86e-06	200	219	8	63a5ae71cfc2aa878a0cea58bdf99da7534b3551
ToppCell	(40)_Monocyte\|World / shred on Cell_type and subtype	CLEC7A NLRC4 HP NFKBIL1 PLAUR DMXL2 FPR1 FPR2	8.52e-06	206	219	8	d78a70f951265ef6df8f64404107be4f53e75d28
ToppCell	facs-Marrow-T-cells-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAG1 CLEC7A CAMTA2 NHLRC2 HP SLC27A4 HMCN1	8.79e-06	148	219	7	b4632029ebd14969bda59a1bd1454eadb8efe563
ToppCell	facs-Marrow-T-cells-3m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAG1 CLEC7A CAMTA2 NHLRC2 HP SLC27A4 HMCN1	8.79e-06	148	219	7	ba277c898678dd36f8dc1d681301c71901b89055
ToppCell	primary_visual_cortex-Non-neuronal-pericyte_cell-Peri-Peri_Kcnj8\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MFGE8 SLC22A8 RIPK3 HRCT1 GJC1 ABCC9 EBF1	1.19e-05	155	219	7	ced64e26962c5c6e6d539f361fe57ab0b399e999
ToppCell	primary_visual_cortex-Non-neuronal-pericyte_cell\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MFGE8 SLC22A8 RIPK3 HRCT1 GJC1 ABCC9 EBF1	1.19e-05	155	219	7	0f24ef6486aef354f0911c06932cb01d1a0525ac
ToppCell	primary_visual_cortex-Non-neuronal-pericyte_cell-Peri\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MFGE8 SLC22A8 RIPK3 HRCT1 GJC1 ABCC9 EBF1	1.19e-05	155	219	7	d8b5145258f075b15080f8739f537f48dd22225e
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Myeloid-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLEC7A GLA HP PLAUR DMXL2 FPR1 FPR2	1.40e-05	159	219	7	a6093b230afdd4d91870d289c6ac91d1856666a3
ToppCell	primary_visual_cortex-Non-neuronal-endothelial_cell-Endo\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PECAM1 SLC22A8 TSPO STRA6 HRCT1 EBF1 HMCN1	1.58e-05	162	219	7	0bdb1e5ba33e162bec1acb28256c1405a7658ee5
ToppCell	primary_visual_cortex-Non-neuronal-endothelial_cell\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PECAM1 SLC22A8 TSPO STRA6 HRCT1 EBF1 HMCN1	1.58e-05	162	219	7	5799a602ef8d83925907e8e34532428be7330228
ToppCell	frontal_cortex-Non-neuronal-endothelial_cell\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PECAM1 SLC22A8 TSPO HRCT1 EBF1 HMCN1 SLC16A4	1.71e-05	164	219	7	6a41a159134e605b80d5e731f9ed5bc803bb531b
ToppCell	frontal_cortex-Non-neuronal-endothelial_cell-Endo\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PECAM1 SLC22A8 TSPO HRCT1 EBF1 HMCN1 SLC16A4	1.71e-05	164	219	7	ec68954fc09b6850273b5e59caa6b09d02151097
ToppCell	frontal_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Ctla2a\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	PECAM1 SLC22A8 TSPO HRCT1 EBF1 HMCN1 SLC16A4	1.85e-05	166	219	7	27af6c906cff1d40d134f0386db7708869691121
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-SPN_Neuron_STR\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GAD2 CHRM1 SLC12A5 LRRC7 FPR1 SLC7A14 IGSF9B	2.00e-05	168	219	7	b87fc63f9e35dfcfc46cb129ea569e73c5e018bb
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-medium_spiny_neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GAD2 CHRM1 SLC12A5 LRRC7 FPR1 SLC7A14 IGSF9B	2.00e-05	168	219	7	b96a48552f4236a95bbcdce2f1b05041086d7101
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLEC7A HP PLAUR SLC27A4 DMXL2 FPR1 FPR2	2.08e-05	169	219	7	e0076aa61b4ef3f836f5750005d0469d3982eb6d
ToppCell	facs-Marrow-Granulocytes-18m-Myeloid-granulocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLEC7A HP PLAUR SLC27A4 DMXL2 FPR1 FPR2	2.08e-05	169	219	7	a5964aef04093b460bbe29d5e2e7389f8fd2d46f
ToppCell	5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Monocytes\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CLEC7A NLRC4 PLAUR TMEM95 FPR1 FPR2 SLC16A5	2.33e-05	172	219	7	cf46810dd1072b6f2171e5d9530351ddc79a055b
ToppCell	PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GLA MRC1 DMXL2 FPR1 FPR2 FLVCR2 MCOLN3	2.33e-05	172	219	7	584af6537685cb459bf0fc298e6f46872016c116
ToppCell	10x5'-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2\|lymph-node_spleen / Manually curated celltypes from each tissue	CLEC7A NLRC4 TSPO PLAUR DMXL2 FPR1 ESPL1	2.42e-05	173	219	7	783b8fa08b9d8f597f251793eae164151662f1f9
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-lung_macrophage\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CLEC7A SLC12A5 PLAUR MFSD1 MRC1 FPR1 FPR3	2.60e-05	175	219	7	f5822cf48777880e670a6a18158ffb31d066c24a
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CLEC7A SLC12A5 PLAUR MFSD1 MRC1 FPR1 FPR3	2.60e-05	175	219	7	cddbd42c1cdfcdf2a41d96198ddb20e684ee6317
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-lung_macrophage-Interstitial_macrophage_perivascular-Interstitial_macrophage_perivascular_L.1.2.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CLEC7A SLC12A5 PLAUR MFSD1 MRC1 FPR1 FPR3	2.60e-05	175	219	7	067f77c5d9ae3cf960b84ece80c25d5193873cbf
ToppCell	343B-Myeloid-Macrophage-FABP4+_Macrophage\|343B / Donor, Lineage, Cell class and subclass (all cells)	CLEC7A NLRC4 MRC1 CARMIL2 FPR1 FPR2 FPR3	2.60e-05	175	219	7	d3890bd0c570bb81434fdd1c5229891cefe2e462
ToppCell	Bronchial_Biopsy-Immune-Luminal_Macrophages\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	PECAM1 CLEC7A NLRC4 HP MRC1 FPR1 FPR3	2.60e-05	175	219	7	1cf99de391552d4f8dbe2ed5b01fc3b8adca61b6
ToppCell	droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CLEC7A PLAUR MRC1 DMXL2 FPR1 FPR2 FLVCR2	2.70e-05	176	219	7	e74ad0db3b05897edcfabeb11008ede2b9eeb638
Computational	Genes in the cancer module 71.	XK SLC12A2 SLC16A5 SLC16A4	6.36e-05	22	109	4	MODULE_71
Drug	CP-320650-01 [172079-28-6]; Up 200; 10uM; MCF7; HT_HG-U133A	GAD2 TRIO MARCHF6 CLEC7A TBC1D8B HIRA SLC35D1 MFGE8 PRAMEF12 CCDC57 SLC16A4	2.64e-06	195	215	11	4379_UP
Drug	t-boc-MLP	FPR1 FPR2 FPR3	3.30e-06	4	215	3	CID000125627
Drug	cyclooctylamine	FPR1 FPR2 FPR3	8.19e-06	5	215	3	CID000002903
Drug	Bumetanide	SLC12A5 SLC12A2 SLC12A4	8.19e-06	5	215	3	DB00887
Drug	toluidine blue	HYAL4 SPAM1 GALNS PECAM1 GLA RBP3 EDA	1.27e-05	82	215	7	CID000007083
Drug	bacteriochlorin A	FPR1 FPR2 FPR3	1.63e-05	6	215	3	CID000159279
Drug	Potassium Chloride	SLC12A5 SLC12A2 SLC12A4	1.63e-05	6	215	3	DB00761
Drug	L-phosphatidyl-glycerol	FPR1 FPR2 FPR3	1.63e-05	6	215	3	CID000454706
Drug	dimethylfumarate	FPR1 FPR2 FPR3	1.63e-05	6	215	3	CID000010262
Drug	PHA-00851261E [724719-49-7]; Down 200; 1uM; PC3; HT_HG-U133A	SETD1A TRIO BCL2L1 ADARB1 MFGE8 MBTPS2 PEX5 STRA6 SLC5A3 LOXL2	1.74e-05	195	215	10	4333_DN
Drug	almotriptan	ADAM10 GLA PLAT LOXL1 LOXL2	2.79e-05	38	215	5	CID000123606
Drug	AC1L3D72	HYAL4 SPAM1 GALNS	2.83e-05	7	215	3	CID000113417
Disease	epilepsy (implicated_via_orthology)	TNIK GAD2 TRIO SLC12A5 KCNK17 KALRN SLC12A2 SLC12A4	1.96e-05	163	205	8	DOID:1826 (implicated_via_orthology)
Disease	Disorder of eye	TMEM67 ABCA4 MKS1 FREM2 STRA6 CPLANE1 RBP3 SNRNP200	1.25e-04	212	205	8	C0015397
Disease	Polydactyly	TMEM67 MKS1 FREM2 MBTPS2 CPLANE1 MEGF8	1.72e-04	117	205	6	C0152427
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	KMT2B TRIO KDM4B	2.09e-04	17	205	3	DOID:0060307 (is_implicated_in)
Disease	Joubert syndrome 1	TMEM67 MKS1 CPLANE1	4.01e-04	21	205	3	C4551568
Disease	hepatocellular adenoma (biomarker_via_orthology)	CYP2E1 HP	4.74e-04	5	205	2	DOID:0050868 (biomarker_via_orthology)
Disease	beta-1,4-galactosyltransferase 1 measurement	FPR1 FPR3	4.74e-04	5	205	2	EFO_0801409
Disease	hemolytic-uremic syndrome (is_marker_for)	HP PLAT	4.74e-04	5	205	2	DOID:12554 (is_marker_for)
Disease	Etat Marbre	TSEN34 XK SLC12A2	5.28e-04	23	205	3	C0266487
Disease	Acidosis, Lactic	PLAT ATAD3A	7.07e-04	6	205	2	C0001125
Disease	disseminated intravascular coagulation (implicated_via_orthology)	FGA PLAT	7.07e-04	6	205	2	DOID:11247 (implicated_via_orthology)
Disease	colorectal adenocarcinoma (is_marker_for)	BCL2L1 STRA6 RICTOR	8.55e-04	27	205	3	DOID:0050861 (is_marker_for)
Disease	acute kidney failure (biomarker_via_orthology)	CYP2E1 BCL2L1 HP FGA	8.66e-04	61	205	4	DOID:3021 (biomarker_via_orthology)
Disease	HDL cholesterol change measurement, physical activity	TTC39B MRM1 FPR3 PIGV	9.21e-04	62	205	4	EFO_0003940, EFO_0007805
Disease	homocitrulline measurement	TNIK NAT8	9.86e-04	7	205	2	EFO_0021018
Disease	Movement Disorders	TSEN34 XK SLC12A2	1.06e-03	29	205	3	C0026650
Disease	Familial aplasia of the vermis	TMEM67 MKS1 CPLANE1	1.17e-03	30	205	3	C0431399
Disease	exfoliation syndrome (is_marker_for)	STRA6 LOXL1	1.31e-03	8	205	2	DOID:13641 (is_marker_for)
Disease	Venous Thromboembolism	FGA PLAT	1.31e-03	8	205	2	C1861172
Disease	Meckel syndrome (implicated_via_orthology)	TMEM67 MKS1	1.31e-03	8	205	2	DOID:0050778 (implicated_via_orthology)
Disease	Schizophrenia	TNIK SETD1A GAD2 PAG1 CYP2E1 CHRM1 ADARB1 CHRM5 SLC12A5 HP PLAT CNR2 SLC12A2 PAFAH1B1 GABBR1	1.37e-03	883	205	15	C0036341
Disease	hypertension	NHLRC2 SLC30A1 PRDM8 RPTOR LRRC7 NUP160 EBF1 ODAD2	1.44e-03	307	205	8	EFO_0000537
Disease	Motor retardation	HACE1 SYT14	1.67e-03	9	205	2	C0424230
Disease	acute lymphoblastic leukemia (is_marker_for)	BCL2L1 TM9SF2 FGA	1.69e-03	34	205	3	DOID:9952 (is_marker_for)
Disease	Retinitis pigmentosa	ABCA4 RBP3 SLC7A14 SNRNP200	1.78e-03	74	205	4	cv:C0035334
Disease	Meckel-Gruber syndrome	TMEM67 MKS1	2.08e-03	10	205	2	cv:C0265215
Disease	Brain hemorrhage	GLA PLAT	2.08e-03	10	205	2	C0553692
Disease	cardiovascular system disease (is_marker_for)	HP PLAUR	2.08e-03	10	205	2	DOID:1287 (is_marker_for)
Disease	waist-hip ratio, high density lipoprotein cholesterol measurement	NHLRC2 EBF1	2.08e-03	10	205	2	EFO_0004343, EFO_0004612
Disease	visceral heterotaxy (implicated_via_orthology)	TMEM67 ODAD2 MEGF8	2.16e-03	37	205	3	DOID:0050545 (implicated_via_orthology)
Disease	Microphthalmos	STRA6 KMT2D	2.54e-03	11	205	2	C0026010
Disease	sialic acid-binding Ig-like lectin 14 measurement	FPR1 FPR2	3.03e-03	12	205	2	EFO_0008284
Disease	Pulmonary Thromboembolisms	FGA PLAT	3.03e-03	12	205	2	C0524702
Disease	Pulmonary Embolism	FGA PLAT	3.03e-03	12	205	2	C0034065
Disease	11beta-hydroxyandrosterone glucuronide measurement	NLRC4 SLC22A8	3.03e-03	12	205	2	EFO_0800573
Disease	pulmonary embolism (biomarker_via_orthology)	HP FGA	3.03e-03	12	205	2	DOID:9477 (biomarker_via_orthology)
Disease	Autoimmune Diseases	PECAM1 HP RBP3	3.11e-03	42	205	3	C0004364
Disease	lymphocyte count	TNIK TTYH1 GAD2 NHLRC2 SLC35D1 TM9SF2 PLAUR NUP160 CNR2 CARMIL2 KALRN FPR1 NAT8 WDR27 EBF1 VARS2 OR10X1 TLN1 MYEOV KDM4B	3.14e-03	1464	205	20	EFO_0004587
Disease	Bardet-Biedl Syndrome	TMEM67 MKS1	3.56e-03	13	205	2	C0752166
Disease	eosinophil count	CPA4 GAD2 ACTRT3 BCL2L1 MKS1 TM9SF2 NFKBIL1 IGKV2D-28 CNR2 CARMIL2 FPR1 FPR3 DNAH7 NDUFA11 SLC12A2 HELZ2 LHFPL5 SNRNP200 GABBR1 FBXW7	3.76e-03	1488	205	20	EFO_0004842
Disease	Bardet-Biedl syndrome (is_implicated_in)	TMEM67 MKS1	4.14e-03	14	205	2	DOID:1935 (is_implicated_in)
Disease	severe acute respiratory syndrome (is_marker_for)	PECAM1 HP PLAT	4.28e-03	47	205	3	DOID:2945 (is_marker_for)
Disease	Seizures	GAD2 SLC30A1 CHRM1 SLC12A5 HACE1 TBCK	4.31e-03	218	205	6	C0036572
Disease	Meckel-Gruber syndrome	TMEM67 MKS1	4.75e-03	15	205	2	C0265215
Disease	chenodeoxycholate measurement	FPR1 HMCN1	4.75e-03	15	205	2	EFO_0010471
Disease	Lymphoma, Follicular, Grade 2	EBF1 KMT2D	4.75e-03	15	205	2	C1956132
Disease	Lymphoma, Follicular, Grade 3	EBF1 KMT2D	4.75e-03	15	205	2	C1956131
Disease	Lymphoma, Follicular, Grade 1	EBF1 KMT2D	4.75e-03	15	205	2	C1956130
Disease	Lymphoma, Large-Cell, Follicular	EBF1 KMT2D	4.75e-03	15	205	2	C0079745
Disease	Lymphoma, Small Cleaved-Cell, Follicular	EBF1 KMT2D	4.75e-03	15	205	2	C0079765
Disease	Lymphoma, Mixed-Cell, Follicular	EBF1 KMT2D	4.75e-03	15	205	2	C0079758
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	TTC39B NHLRC2 ADAM10 PLAUR SLC12A4 HELZ2	5.02e-03	225	205	6	EFO_0008317, EFO_0020947
Disease	alopecia areata	FPR1 FPR2 SYT14	5.09e-03	50	205	3	EFO_0004192
Disease	Rolandic epilepsy	ALDH1L2 KALRN	5.41e-03	16	205	2	Orphanet_1945
Disease	Generalized seizures	GAD2 SLC30A1 CHRM1 SLC12A5	5.47e-03	101	205	4	C0234533
Disease	Clonic Seizures	GAD2 SLC30A1 CHRM1 SLC12A5	5.47e-03	101	205	4	C0234535
Disease	Convulsive Seizures	GAD2 SLC30A1 CHRM1 SLC12A5	5.47e-03	101	205	4	C0751494
Disease	Seizures, Sensory	GAD2 SLC30A1 CHRM1 SLC12A5	5.47e-03	101	205	4	C0751496
Disease	Non-epileptic convulsion	GAD2 SLC30A1 CHRM1 SLC12A5	5.47e-03	101	205	4	C0751056
Disease	Atonic Absence Seizures	GAD2 SLC30A1 CHRM1 SLC12A5	5.47e-03	101	205	4	C0751123
Disease	Complex partial seizures	GAD2 SLC30A1 CHRM1 SLC12A5	5.47e-03	101	205	4	C0149958
Disease	Single Seizure	GAD2 SLC30A1 CHRM1 SLC12A5	5.47e-03	101	205	4	C0751110
Disease	Nonepileptic Seizures	GAD2 SLC30A1 CHRM1 SLC12A5	5.47e-03	101	205	4	C3495874
Disease	Visual seizure	GAD2 SLC30A1 CHRM1 SLC12A5	5.47e-03	101	205	4	C0270824
Disease	Epileptic drop attack	GAD2 SLC30A1 CHRM1 SLC12A5	5.47e-03	101	205	4	C0270846
Disease	Vertiginous seizure	GAD2 SLC30A1 CHRM1 SLC12A5	5.47e-03	101	205	4	C0422855
Disease	Gustatory seizure	GAD2 SLC30A1 CHRM1 SLC12A5	5.47e-03	101	205	4	C0422854
Disease	Seizures, Somatosensory	GAD2 SLC30A1 CHRM1 SLC12A5	5.47e-03	101	205	4	C0422850
Disease	Olfactory seizure	GAD2 SLC30A1 CHRM1 SLC12A5	5.47e-03	101	205	4	C0422853
Disease	Seizures, Auditory	GAD2 SLC30A1 CHRM1 SLC12A5	5.47e-03	101	205	4	C0422852
Disease	Generalized Absence Seizures	GAD2 SLC30A1 CHRM1 SLC12A5	5.47e-03	101	205	4	C4505436
Disease	Jacksonian Seizure	GAD2 SLC30A1 CHRM1 SLC12A5	5.47e-03	101	205	4	C0022333
Disease	obesity (is_marker_for)	HP PLAT PLAUR SLC27A4	5.47e-03	101	205	4	DOID:9970 (is_marker_for)
Disease	Epileptic Seizures	GAD2 SLC30A1 CHRM1 SLC12A5	5.47e-03	101	205	4	C4317109
Disease	Absence Seizures	GAD2 SLC30A1 CHRM1 SLC12A5	5.66e-03	102	205	4	C4316903
Disease	Convulsions	GAD2 SLC30A1 CHRM1 SLC12A5	5.66e-03	102	205	4	C4048158
Disease	Tonic Seizures	GAD2 SLC30A1 CHRM1 SLC12A5	5.66e-03	102	205	4	C0270844
Disease	Childhood Acute Lymphoblastic Leukemia	PAG1 CYP2E1 FBXW7	5.69e-03	52	205	3	C0023452
Disease	Liver Cirrhosis	TMEM67 SLC22A8 CNR2 LOXL1	5.86e-03	103	205	4	C0023890
Disease	Retinitis Pigmentosa	ABCA4 RBP3 SLC7A14 SNRNP200	6.06e-03	104	205	4	C0035334
Disease	Seizures, Focal	GAD2 SLC30A1 CHRM1 SLC12A5	6.06e-03	104	205	4	C0751495
Disease	Myoclonic Seizures	GAD2 SLC30A1 CHRM1 SLC12A5	6.06e-03	104	205	4	C4317123
Disease	Tonic - clonic seizures	GAD2 SLC30A1 CHRM1 SLC12A5	6.06e-03	104	205	4	C0494475
Disease	eosinophil percentage of leukocytes	KMT2B ACTRT3 BCL2L1 MKS1 TM9SF2 NFKBIL1 PLAUR CNR2 FPR1 FPR3 LHFPL5 FBXW7	6.21e-03	746	205	12	EFO_0007991
Disease	Fibrosis, Liver	TMEM67 SLC22A8 CNR2 LOXL1	6.26e-03	105	205	4	C0239946
Disease	lifestyle measurement, depressive symptom measurement	HDAC11 YIPF1 EBF1 SLC7A14	6.26e-03	105	205	4	EFO_0007006, EFO_0010724
Disease	Meckel syndrome type 1	TMEM67 MKS1	6.83e-03	18	205	2	C3714506
Disease	Age-related macular degeneration	ABCA4 HMCN1	6.83e-03	18	205	2	cv:C0242383
Disease	Bardet-Biedl syndrome	TMEM67 MKS1	6.83e-03	18	205	2	cv:C0752166

Protein segments in the cluster

Peptide	Gene	Start	Entry
LLVLVLSWGSMGLEA	TTYH1	251	Q9H313
MIWGTDVLKNRSVTG	BEND5	331	Q7L4P6
ELAITMGIVSWLRRG	AMER3	501	Q8N944
LSENQGIATWGIVVM	DMAC1	91	Q96GE9
RFLMWDIGGQESLRS	ARL5A	61	Q9Y689
ISSARAGGLAEWVLM	CHTF8	6	P0CG13
QGINLRSWGGILSDM	ABCA4	266	P78363
ERKISVWMGGSILAS	ACTRT3	331	Q9BYD9
VLILLLSWAAGMGGQ	ADAM10	6	O14672
MLQGSSWREQLEGVL	CARMIL2	826	Q6F5E8
RGASAINWTLIMGDK	ALDH1L2	136	Q3SY69
EGMSGREIAQLAVSW	ATAD3A	571	Q9NVI7
VNLLDSRTVMGDLGW	EPHA5	61	P54756
ALGVSGLVWLLMVAL	GPR31	131	O00270
TIMAGKLAVERGWAI	HDAC11	121	Q96DB2
MAWSFRAKVQLGGLL	CLDN25	1	C9JDP6
ERTGAVGLSETMSWL	CAMTA2	971	O94983
NRWFLTGMTVAGVVL	BCL2L1	211	Q07817
GLAWAVAMINRQEIG	GLA	346	P06280
WIIAMKDGSVLREGT	ABCC9	881	O60706
AWVLMQLATAQAGII	ACSF2	136	Q96CM8
SLSWVRDGILVVGMD	DMXL2	1251	Q8TDJ6
AVVTWALGVMLASAI	SLC7A4	476	O43246
QLLGLTLVAMTGAWL	CYB561	21	P49447
RGTAIGQRLVTWNNM	DISP1	226	Q96F81
MGRIQEVGWVTAGLV	ARMCX4	1	Q5H9R4
TRGRALVTLGIMWVL	CNR2	146	P34972
VLMITGSWIIGSINA	OR2L3	141	Q8NG85
AASLVKMGRLEGWEV	NDUFA11	121	Q86Y39
LSLLILAMWVVGSGQ	PCDHA9	16	Q9Y5H5
MSALGVTVALLVWAA	CYP2E1	1	P05181
LMTLVGHDNWVRGVL	PAFAH1B1	331	P43034
TDVALLVTMGGWLTL	LRRC3C	221	A6NJW4
GILGWRSEKTEMVNG	ANKRD13B	256	Q86YJ7
MWTLGRRAVAGLLAS	FXN	1	Q16595
NTMGWVSDQGLLLLI	NOL9	406	Q5SY16
IMIAWNGIERLRAGL	OSGEPL1	361	Q9H4B0
QLSTGLDMVGLAADW	GAD2	181	Q05329
GNLLIMATVWSERSL	OR10H5	41	Q8NGA6
GNLLIMATVWSERSL	OR10H2	41	O60403
AGNLIIMGLTWVDRS	OR10X1	56	Q8NGY0
VAWTGGLLHSMIQIL	OR4C15	146	Q8NGM1
MSALGAVIALLLWGQ	HP	1	P00738
STLLQRIAMLWGSGK	NLRC4	176	Q9NPP4
NLLRRMWVTGVVTQG	MFGE8	131	Q08431
MWVTGVVTQGASRLA	MFGE8	136	Q08431
LLGTSTMLVWLGVIR	MCOLN3	376	Q8TDD5
LAWGCISGLQQERSM	LRRC7	526	Q96NW7
MLGAWAVEGTAVALL	MLEC	1	Q14165
GSRMAWTLIEQLQGG	GABBR1	531	Q9UBS5
VLGNGLVIWVAGFRM	FPR2	41	P25090
QLLGLLMLWVSGSSG	IGKV2D-28	6	P01615
LSDMSQEWRIGGNTI	FREM2	1036	Q5SZK8
VLGNGLVIWVAGFRM	FPR3	41	P25089
MNIWSLRDGSVLQTV	HERC1	3771	Q15751
NSRAVGVMWGTLTIC	LHFPL5	21	Q8TAF8
MALARGSRQLGALVW	LOXL1	1	Q08397
LVERNGSLVWGMVCG	LOXL2	451	Q9Y4K0
RVGWSTMQASLDLGT	DDX1	146	Q92499
LGIRQAMTSIWNALV	ECPAS	1136	Q5VYK3
MLGLLGSTALVGWIT	HRCT1	1	Q6UXD1
RWMGANAERSLLILG	PNMA6E	11	A0A0J9YXQ4
LLSNTTSMGRWELVG	KCNK17	91	Q96T54
VLMITGSWIIGSINA	OR2L8	141	Q8NGY9
TMVGNLLIWVTTIGS	OR4A16	36	Q8NH70
GGAMSENIWSTLRLA	PEX5	596	P50542
ENIWSTLRLALSMLG	PEX5	601	P50542
AQGATMWLGVLLTLL	PECAM1	6	P16284
FIAVVQAIVRMAGGW	GGTLC1	196	Q9BX51
ERMVGSGLLWLALVS	GP2	6	P55259
GMGQGVVREWFDILS	HACE1	591	Q8IYU2
QVLGWIRNGESMLNA	KALRN	901	O60229
AWIVSGNIRENILMG	ABCC11	581	Q96J66
ATKLDGGQLVWETLM	MEGF8	1481	Q7Z7M0
GGQLVWETLMDSRLS	MEGF8	1486	Q7Z7M0
VAQWNIGSLRTILDM	KDM4B	146	O94953
MLAINVGLTSLDLSW	LRRC74A	241	Q0VAA2
LTVVTVEALGGWRMG	MYEOV	261	Q96EZ4
ELTWERMLGLDGSLV	MARCHF6	271	O60337
ARIGSTVNMNLMGWL	MFSD1	181	Q9H3U5
GIDWMVRHGRSLALS	GCN1	2476	Q92616
LENVWLMGGLSVLTS	KMT2B	1181	Q9UMN6
RSQIETWELGRVMGA	NFKBIL1	351	Q9UBC1
TWELGRVMGAVTALS	NFKBIL1	356	Q9UBC1
TWDGVLQGERLLTMS	ADARB1	541	P78563
MGIIATFRSWAGIIN	RICTOR	286	Q6R327
SGSEVQRGDILWIAM	NHLRC2	346	Q8NBF2
GLGLTLIDALDTMWI	MAN1B1	286	Q9UKM7
RAWGDISGFMIVILT	PKD1L2	2306	Q7Z442
LWEIGNMLDTGRNGE	HMCN1	2771	Q96RW7
MEGNQTWITDITLLG	OR2A2	1	Q6IF42
QWAGEIENLGMVLLG	FANCB	171	Q8NB91
GSRSQQWLLRNMTLG	GALNT13	541	Q8IUC8
EGSWILVGMAVQGSR	PRSS36	776	Q5K4E3
WGRFSQLGAELMKTL	PRAMEF12	426	O95522
AIAIGQAMVDGRWLD	PIKFYVE	406	Q9Y2I7
WQLLLVLSAAGMGAS	GALNS	11	P34059
LSGGVLNDWSRITMN	EDA	266	Q92838
LRWVLVTAGVRLAMG	ESPL1	1161	Q14674
DSRQMVWVLSGNSLI	IL36B	16	Q9NZH7
LAEWRMQVELNIGSG	GSTT4	191	A0A1W2PR19
ETWNIGIILLLATMA	MT-CYB	111	P00156
ALNTFGSIGRLLEWM	CPLANE1	1736	Q9H799
RVLSMTGVGQTLVWC	GCHFR	66	P30047
NIWEMLHLGFGTIRD	GJC1	246	P36383
MRWILFIGALIGSSI	CPA4	1	Q9UI42
MTVTGLGWRDVLEAI	DUSP15	101	Q9H1R2
NVVMTAGWLVIAVGL	HACD2	46	Q6Y1H2
MGTLGEAVTIRTWNI	DNAH7	2951	Q8WXX0
TGGVWSSQMRDNIII	FBXW7	421	Q969H0
VIRGWDEALLTMSKG	FKBP3	171	Q00688
LGAAGIVIWGDMNLT	HYAL4	331	Q2M3T9
FMLLSQGLGVLRVAW	GPAT2	216	Q6NUI2
RAALMIGLAWLVSFV	CHRM1	141	P11229
ASGTLQDMWRLLDLG	CCDC57	826	Q2TAC2
AVRTWMQGAGVLDAN	EBF1	26	Q9UH73
SLMLLLAAGDAVWVR	C1QTNF8	206	P60827
AGMLGAVISGIWLDR	FLVCR2	356	Q9UPI3
ETSLGGWLLIQQRMD	FGA	666	P02671
GWLLIQQRMDGSLNF	FGA	671	P02671
GSVLLAANVTLGLWM	MBTPS2	501	O43462
MALRWGIVSVGLISS	DHDH	1	Q9UQ10
NVILGRWAILAMVLG	DSC1	686	Q08554
QLLGLLMLWVSGSSG	IGKV2-28	6	A0A075B6P5
VGNLISELVRSMGWA	CUL9	306	Q8IWT3
LGASGIVIWGTLSIM	SPAM1	331	P38567
DVITVSNGGRIMRSW	EMC1	96	Q8N766
IMDISWTLNGLGILV	HIRA	331	P54198
MAVWEAEQLGGLQRG	HELZ2	1	Q9BYK8
ISGRVVDAVDGWMLN	CERCAM	346	Q5T4B2
GWMLNSSAIRNLGVD	CERCAM	356	Q5T4B2
RIWRLLMGETGFNSS	DNAJC22	241	Q8N4W6
WGRFAELGAELMNTL	PRAMEF8	426	Q5VWM4
IRQTGMGVSNLWTRV	SLC22A8	441	Q8TCC7
AQRLIMAGTVVWIGI	SCAP	516	Q12770
MTGTLERENWISGGK	FAM87A	1	P0C7U9
VGSMSGLAIWDRALV	PTX4	421	Q96A99
TRVNEWVIFIMGGLI	OR1E2	201	P47887
GNLLIMATVWSERSL	OR10H1	41	Q9Y4A9
MNGRLCTVLVAGAWV	OR10G2	141	Q8NGC3
LRLTWVVGIAGIMES	SLC12A5	141	Q9H2X9
GAGVAMAVWSLLSAR	TMEM67	6	Q5HYA8
DTRVNEWVIFIMGGL	OR1E1	191	P30953
VAMRTGIAGGLWDVL	MRC1	601	P22897
ETGSDLLLFWVGRMV	VARS2	616	Q5ST30
MIGWISLGLNSSGEE	SYT14	516	Q8NB59
RWLFGINIVLTIMTG	TMC3	146	Q7Z5M5
GVMQIGWATRDSKFL	RSPRY1	371	Q96DX4
WLVALAGGMISSIAV	SLC25A34	206	Q6PIV7
MALLSTVRGATWGRL	MRM1	1	Q6IN84
MGVALRKLTQWTAAG	ODAD2	1	Q5T2S8
VLGNGLVIWVAGFRM	FPR1	41	P21462
AAQDVWMLLGGRLLT	SLC2A8	116	Q9NY64
SVLVGLAMEVGLVLW	MT-ND6	91	P03923
GSSEGLMWLRLVQSA	PRDM8	81	Q9NQV8
IQALWAGGAESLQMT	EPHB6	701	O15197
SGDNGISVTMILVAW	SMIM14	46	Q96QK8
LAGRSMTWVAIGASL	SLC5A3	41	P53794
AVGLWAMLKTNRGTI	SLC5A4	41	Q9NY91
LQSMVQEGGFRSLWR	SLC25A41	136	Q8N5S1
ILRWTIDLKNGSGDM	SCP2D1	81	Q9UJQ7
GQITMWDLASGKLLR	VPS8	221	Q8N3P4
GLGQMVATVAVLWVG	SLC35D1	76	Q9NTN3
LMRLGDAVIWGTGQL	NUP160	741	Q12769
GQMQITLWGSLAAVA	PAG1	11	Q9NWQ8
NSLELMDRLGAQWGG	SETD1A	661	O15047
GLLMSSGDVRIVRIW	RPTOR	1136	Q8N122
ILFLRLTWMVGTAGV	SLC12A4	136	Q9UP95
LTWMVGTAGVLQALL	SLC12A4	141	Q9UP95
LVRAMRLSFVGELGW	SARDH	721	Q9UL12
NVLVGAMVATWRVLL	STRA6	521	Q9BX79
RAGIMIGLAWLISFI	CHRM5	146	P08912
ALLIWLHGTLMTQGD	ANKDD1B	476	A6NHY2
LQVMGIALAVLGWLA	CLDN4	6	O14493
AVVLGTMAIWRSNSG	CLEC7A	61	Q9BXN2
LGARIFVSSIKNGMW	RNF17	466	Q9BXT8
MWRLALGGVFLAAAQ	TMEM95	1	Q3KNT9
LTFSAMGQLERGRVW	PIGV	176	Q9NUD9
MGQLERGRVWTSVLL	PIGV	181	Q9NUD9
ISRWMADSVGTLNGL	SLC7A14	166	Q8TBB6
LGAWLNFAGSVLRMV	SLC49A3	101	Q6UXD7
WAGMLLVTLAAVSLT	TMEM268	131	Q5VZI3
WGRFAELGAELMNTL	PRAMEF7	426	Q5VXH5
WGVNLLVGTENGLML	TNIK	1056	Q9UKE5
NDGRMTLVGIISWGL	PLAT	521	P00750
SLTITLLMTARLWGG	PLAUR	316	Q03405
EGNWGRLLEQVGTMA	ZBED2	136	Q9BTP6
RLLEQVGTMALWASQ	ZBED2	141	Q9BTP6
VRWILVMIALGISGS	YIPF1	226	Q9Y548
WFLGGSSQRRNMALL	TTC39B	56	Q5VTQ0
WGNLMGTSALVLDLR	RBP3	156	P10745
MQSLGWATLVGEITA	RBP3	556	P10745
GLMLTASEDGSVRLW	TEP1	2251	Q99973
SEQIGWIGSIMSSLR	SLC16A4	56	O15374
NALASMGVSLGITLW	SLC16A5	141	O15375
GMEGGILKSRIVTWE	MKS1	171	Q9NXB0
SFGILMWAVLAGREV	RIPK3	206	Q9Y572
TLRGELWMLFSGAVN	TBC1D8B	491	Q0IIM8
RMALGNGLRQSIWTN	SLC27A4	356	Q6P1M0
NLGWTLMEDGSIRIE	IGSF9B	371	Q9UPX0
MLVVEVANGRSLVWG	TSEN34	1	Q9BSV6
DGQWSQGLISAARMV	TLN1	2386	Q9Y490
LMSWINGIRGLVSSD	SPTAN1	1351	Q13813
GVMLFIRLSWIVGQA	SLC12A2	301	P55011
AIGVGDGMIRVWNTL	GEMIN5	396	Q8TEQ6
LMWTAVIGTNNIHGR	TMPRSS12	131	Q86WS5
MGADRWNALALLSGS	PIGZ	151	Q86VD9
MRGLTWAALLGVEGA	TBCK	471	Q8TEA7
GWLGTVVSTLMALLL	SLC14A1	96	Q13336
VLVRGMSGRLAWAQQ	RALGAPB	976	Q86X10
WIMTTATRRQGNLGE	ZNF226	66	Q9NYT6
WTELGALDILQMLGR	SNRNP200	841	O75643
LWDVQSGQMLRLLVG	WDR38	131	Q5JTN6
IMNLILWGEGSSAAI	TM9SF2	451	Q99805
MGTGALRSAQIWSLA	ZNF445	156	P59923
VMLENLALLSSLGSW	ZNF548	36	Q8NEK5
VSGVLRGNWAMLEGS	WDR4	336	P57081
FLTTAIGDGMRLWDL	WDR27	726	A2RRH5
AIGIAAWGMVSNRDT	TRPM8	211	Q7Z2W7
TFGWIRAEVMGALVN	SLC30A1	71	Q9Y6M5
GGDRMWQALTLLFSL	XK	31	P51811
GARQMGWALVDLLLV	TSPO	101	P30536
MALQSTLGAVWLGLL	TRAV2	1	A0A0B4J234
GWIRNGESMLNAGLI	TRIO	921	O75962
WASARSMVKLIGITG	PLPP7	106	Q8NBV4
GSRRWMLQLIMQLGS	TMEM101	6	Q96IK0
MLGSRALAQQWRGTS	VWA5B1	926	Q5TIE3
IANGTLDTLMWGMLN	ZRANB3	446	Q5FWF4
IILAVWGMLAVSGIT	TM7SF3	486	Q9NS93
WGMLAVSGITLQIRR	TM7SF3	491	Q9NS93
EWTQMASLNIGRAGA	KLHL1	726	Q9NR64
RFEGVWLTETGMALL	KMT2D	1586	O14686
ESDRQWVVGLLSRGM	NAT8	11	Q9UHE5